FI110944B - Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi Download PDFInfo
- Publication number
- FI110944B FI110944B FI943543A FI943543A FI110944B FI 110944 B FI110944 B FI 110944B FI 943543 A FI943543 A FI 943543A FI 943543 A FI943543 A FI 943543A FI 110944 B FI110944 B FI 110944B
- Authority
- FI
- Finland
- Prior art keywords
- pyrrolo
- benzodiazepine
- ylcarbonyl
- phenyl
- give
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 20
- 238000002360 preparation method Methods 0.000 title claims description 14
- 230000008569 process Effects 0.000 title claims description 8
- JGEMFVRZSFKXSR-UHFFFAOYSA-N N1=CCN2C1=CN=CC=C2 Chemical class N1=CCN2C1=CN=CC=C2 JGEMFVRZSFKXSR-UHFFFAOYSA-N 0.000 title claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 208
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 71
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 125000003118 aryl group Chemical group 0.000 claims abstract description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 6
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 578
- -1 5H-pyrrolo [2,1-c] [1,4] benzodiazepine-10 (11H) -ylcarbonyl Chemical group 0.000 claims description 222
- 150000001875 compounds Chemical class 0.000 claims description 82
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 75
- 150000002367 halogens Chemical class 0.000 claims description 33
- 229910052739 hydrogen Inorganic materials 0.000 claims description 32
- 229910052736 halogen Inorganic materials 0.000 claims description 31
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 30
- 239000000460 chlorine Substances 0.000 claims description 29
- 239000001257 hydrogen Substances 0.000 claims description 28
- 229910052786 argon Inorganic materials 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 150000002431 hydrogen Chemical class 0.000 claims description 15
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 239000003086 colorant Substances 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 5
- 150000008064 anhydrides Chemical class 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 claims description 5
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 claims description 5
- 239000002002 slurry Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 3
- 125000003435 aroyl group Chemical group 0.000 claims description 2
- 239000000571 coke Substances 0.000 claims description 2
- 125000002541 furyl group Chemical group 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 239000012026 peptide coupling reagents Substances 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 229910052721 tungsten Inorganic materials 0.000 claims description 2
- 241000277284 Salvelinus fontinalis Species 0.000 claims 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- PPHTXRNHTVLQED-UHFFFAOYSA-N lixivaptan Chemical compound CC1=CC=C(F)C=C1C(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 PPHTXRNHTVLQED-UHFFFAOYSA-N 0.000 claims 1
- 230000001338 necrotic effect Effects 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract description 46
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 8
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract description 6
- LRANPJDWHYRCER-UHFFFAOYSA-N 1,2-diazepine Chemical compound N1C=CC=CC=N1 LRANPJDWHYRCER-UHFFFAOYSA-N 0.000 abstract description 3
- 150000002148 esters Chemical class 0.000 abstract description 3
- 229930192474 thiophene Natural products 0.000 abstract description 3
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 353
- 239000007787 solid Substances 0.000 description 281
- 239000000203 mixture Substances 0.000 description 258
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 246
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 172
- 239000000243 solution Substances 0.000 description 170
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 159
- 229910001868 water Inorganic materials 0.000 description 137
- 239000000047 product Substances 0.000 description 134
- 239000011541 reaction mixture Substances 0.000 description 128
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 123
- 235000019439 ethyl acetate Nutrition 0.000 description 118
- 239000011734 sodium Substances 0.000 description 113
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 96
- 239000000706 filtrate Substances 0.000 description 96
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 93
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 84
- 239000012267 brine Substances 0.000 description 84
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 84
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 75
- 238000003756 stirring Methods 0.000 description 74
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 67
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 56
- 239000000391 magnesium silicate Substances 0.000 description 56
- 229910052919 magnesium silicate Inorganic materials 0.000 description 56
- 235000019792 magnesium silicate Nutrition 0.000 description 56
- 239000003039 volatile agent Substances 0.000 description 51
- 239000012044 organic layer Substances 0.000 description 50
- 239000002904 solvent Substances 0.000 description 50
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 48
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 45
- 239000013078 crystal Substances 0.000 description 45
- 239000000741 silica gel Substances 0.000 description 43
- 229910002027 silica gel Inorganic materials 0.000 description 43
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
- 238000003818 flash chromatography Methods 0.000 description 42
- 235000019441 ethanol Nutrition 0.000 description 38
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 36
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 34
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- 238000010992 reflux Methods 0.000 description 33
- 239000005909 Kieselgur Substances 0.000 description 32
- 239000000725 suspension Substances 0.000 description 32
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 31
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 30
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 28
- MSWOGZZRHMRJAK-UHFFFAOYSA-N (4-aminophenyl)-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 MSWOGZZRHMRJAK-UHFFFAOYSA-N 0.000 description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 25
- 238000001816 cooling Methods 0.000 description 25
- 239000010410 layer Substances 0.000 description 25
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 24
- 239000000284 extract Substances 0.000 description 24
- 229910052763 palladium Inorganic materials 0.000 description 24
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 24
- 238000001819 mass spectrum Methods 0.000 description 23
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- 238000009739 binding Methods 0.000 description 22
- 230000027455 binding Effects 0.000 description 21
- 238000010276 construction Methods 0.000 description 21
- 229960003726 vasopressin Drugs 0.000 description 21
- 108010004977 Vasopressins Proteins 0.000 description 20
- 229920006395 saturated elastomer Polymers 0.000 description 20
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 19
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 18
- 102000002852 Vasopressins Human genes 0.000 description 18
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 17
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 17
- 239000007789 gas Substances 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- 241000700159 Rattus Species 0.000 description 16
- 239000006260 foam Substances 0.000 description 16
- 239000005457 ice water Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 15
- 102000005962 receptors Human genes 0.000 description 15
- 108020003175 receptors Proteins 0.000 description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 14
- 239000012312 sodium hydride Substances 0.000 description 14
- 229910000104 sodium hydride Inorganic materials 0.000 description 14
- 239000005557 antagonist Substances 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 13
- RPQCNCIFKALLIW-UHFFFAOYSA-N 4-[(2-methylbenzoyl)amino]benzoyl chloride Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(Cl)=O)C=C1 RPQCNCIFKALLIW-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical class [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 11
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 11
- GPZXFICWCMCQPF-UHFFFAOYSA-N 2-methylbenzoyl chloride Chemical compound CC1=CC=CC=C1C(Cl)=O GPZXFICWCMCQPF-UHFFFAOYSA-N 0.000 description 10
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 229940098773 bovine serum albumin Drugs 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- ZSKGQVFRTSEPJT-UHFFFAOYSA-N pyrrole-2-carboxaldehyde Chemical compound O=CC1=CC=CN1 ZSKGQVFRTSEPJT-UHFFFAOYSA-N 0.000 description 10
- HFEFMUSTGZNOPY-UHFFFAOYSA-N OOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOO HFEFMUSTGZNOPY-UHFFFAOYSA-N 0.000 description 9
- 102000004136 Vasopressin Receptors Human genes 0.000 description 9
- 108090000643 Vasopressin Receptors Proteins 0.000 description 9
- 238000004587 chromatography analysis Methods 0.000 description 9
- 239000012065 filter cake Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical compound N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 description 8
- XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical compound C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 description 8
- MSNVESLISHTIRS-UHFFFAOYSA-N 9h-pyrrolo[2,1-c][1,4]benzodiazepine Chemical compound N1=C2C=CC=CC2=CN2CC=CC2=C1 MSNVESLISHTIRS-UHFFFAOYSA-N 0.000 description 8
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 8
- 229940116211 Vasopressin antagonist Drugs 0.000 description 8
- 235000011054 acetic acid Nutrition 0.000 description 8
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 239000003038 vasopressin antagonist Substances 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 7
- 239000005711 Benzoic acid Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000007832 Na2SO4 Substances 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 230000003204 osmotic effect Effects 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- SQKQWKKZZCFSAW-UHFFFAOYSA-N 10h-imidazo[2,1-c][1,4]benzodiazepine Chemical compound N1=CC2=NC=CN2CC2=CC=CC=C21 SQKQWKKZZCFSAW-UHFFFAOYSA-N 0.000 description 6
- POAQFKSUTQWHMZ-UHFFFAOYSA-N 6,11-dihydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine Chemical compound C1NC2=CC=CC=C2CN2C=CC=C12 POAQFKSUTQWHMZ-UHFFFAOYSA-N 0.000 description 6
- JYWICBLYDVJZER-UHFFFAOYSA-N 6,7-dihydro-5h-pyrrolo[1,2-a][1,5]benzodiazepine Chemical compound N1CCC2=CC=CN2C2=CC=CC=C21 JYWICBLYDVJZER-UHFFFAOYSA-N 0.000 description 6
- 206010007559 Cardiac failure congestive Diseases 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 206010019280 Heart failures Diseases 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 6
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 6
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 6
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 6
- ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical compound N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 description 5
- LEMYTIOJRJYGRA-UHFFFAOYSA-N 9,10-dihydro-4h-furo[2,3-e]pyrrolo[1,2-a][1,4 ]diazepine Chemical compound C1N2C=CC=C2CNC2=C1C=CO2 LEMYTIOJRJYGRA-UHFFFAOYSA-N 0.000 description 5
- 108010039627 Aprotinin Proteins 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 229960004405 aprotinin Drugs 0.000 description 5
- 229940049706 benzodiazepine Drugs 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 125000002576 diazepinyl group Chemical class N1N=C(C=CC=C1)* 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PKAYIRZWXVXVLM-UHFFFAOYSA-N 11h-pyrrolo[2,1-c][1,4]benzodiazepine Chemical compound N1=CC2=CC=CN2CC2=CC=CC=C21 PKAYIRZWXVXVLM-UHFFFAOYSA-N 0.000 description 4
- HZABUXCSZMLBHU-UHFFFAOYSA-N 1H-1,4-benzodiazepine-3-carboxylic acid Chemical compound C1=NC(C(=O)O)=CNC2=CC=CC=C21 HZABUXCSZMLBHU-UHFFFAOYSA-N 0.000 description 4
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 4
- UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 4
- CEOCVKWBUWKBKA-UHFFFAOYSA-N 2,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1Cl CEOCVKWBUWKBKA-UHFFFAOYSA-N 0.000 description 4
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 4
- XATSGMYOTPTYDU-UHFFFAOYSA-N 4,10-dihydroimidazo[2,1-c][1,4]benzodiazepin-5-yl-(4-nitrophenyl)methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CN=C2C1 XATSGMYOTPTYDU-UHFFFAOYSA-N 0.000 description 4
- GWSCOZZXRQEHTO-UHFFFAOYSA-N 5,10-dihydro-4h-imidazo[2,1-c][1,4]benzodiazepine Chemical compound C1NC2=CC=CC=C2CN2C=CN=C12 GWSCOZZXRQEHTO-UHFFFAOYSA-N 0.000 description 4
- NVVSEZNTWWXLEJ-UHFFFAOYSA-N 5,10-dihydro-4h-pyrazolo[5,1-c][1,4]benzodiazepine Chemical compound C1NC2=CC=CC=C2CN2N=CC=C12 NVVSEZNTWWXLEJ-UHFFFAOYSA-N 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- UIQWBVPFHHQZHH-UHFFFAOYSA-N OOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOO UIQWBVPFHHQZHH-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 4
- 108010052968 leupeptin Proteins 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 229960001723 oxytocin Drugs 0.000 description 4
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- MEFKFJOEVLUFAY-UHFFFAOYSA-N (2,2,2-trichloroacetyl) 2,2,2-trichloroacetate Chemical compound ClC(Cl)(Cl)C(=O)OC(=O)C(Cl)(Cl)Cl MEFKFJOEVLUFAY-UHFFFAOYSA-N 0.000 description 3
- CDRHFDPDVMEHPP-UHFFFAOYSA-N (4-amino-3-methoxyphenyl)-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound C1=C(N)C(OC)=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C1 CDRHFDPDVMEHPP-UHFFFAOYSA-N 0.000 description 3
- VQDDYEWTCOIXPQ-UHFFFAOYSA-N (4-aminophenyl)-(4h-pyrrolo[1,2-a]quinoxalin-5-yl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2C1 VQDDYEWTCOIXPQ-UHFFFAOYSA-N 0.000 description 3
- LMLICLRBZPFXMK-UHFFFAOYSA-N 1-(2-nitrophenyl)pyrrole-2-carbaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1N1C(C=O)=CC=C1 LMLICLRBZPFXMK-UHFFFAOYSA-N 0.000 description 3
- WZZJEUXMXSHWOQ-UHFFFAOYSA-N 2-(3-methyl-1-benzothiophen-2-yl)acetyl chloride Chemical compound C1=CC=C2C(C)=C(CC(Cl)=O)SC2=C1 WZZJEUXMXSHWOQ-UHFFFAOYSA-N 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- JTCAKXCOOSKORL-UHFFFAOYSA-N 2-chloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-phenylacetamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=CC=1NC(=O)C(Cl)C1=CC=CC=C1 JTCAKXCOOSKORL-UHFFFAOYSA-N 0.000 description 3
- OIDAXOKENZZBPF-UHFFFAOYSA-N 3-fluoro-2-methylbenzoyl chloride Chemical compound CC1=C(F)C=CC=C1C(Cl)=O OIDAXOKENZZBPF-UHFFFAOYSA-N 0.000 description 3
- ZNYXWEUONVZJDQ-UHFFFAOYSA-N 4,10-dihydro-4-(4-nitrobenzoyl)-5h-pyrrolo-[1,2-a]thieno[3,2-e][1,4]-diazepine Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C(C=CS2)=C2CN2C=CC=C2C1 ZNYXWEUONVZJDQ-UHFFFAOYSA-N 0.000 description 3
- QQCJVZLRLFITOJ-UHFFFAOYSA-N 4,10-dihydro-5h-pyrrolo[1,2-a]thieno[3,2-e][1,4]diazepine Chemical compound C1N2C=CC=C2CNC2=C1SC=C2 QQCJVZLRLFITOJ-UHFFFAOYSA-N 0.000 description 3
- SVJWZRQLGHYOGG-UHFFFAOYSA-N 4,5-dihydropyrrolo[1,2-a]quinoxaline Chemical compound C1NC2=CC=CC=C2N2C1=CC=C2 SVJWZRQLGHYOGG-UHFFFAOYSA-N 0.000 description 3
- OKEFBVALFLRAFV-UHFFFAOYSA-N 4-chloro-2-methoxybenzoyl chloride Chemical compound COC1=CC(Cl)=CC=C1C(Cl)=O OKEFBVALFLRAFV-UHFFFAOYSA-N 0.000 description 3
- DGZAAHXBBWDLNQ-UHFFFAOYSA-N 6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl-(3-methoxy-4-nitrophenyl)methanone Chemical compound C1=C([N+]([O-])=O)C(OC)=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C1 DGZAAHXBBWDLNQ-UHFFFAOYSA-N 0.000 description 3
- AJTFSJMWEFZRFS-UHFFFAOYSA-N 9,10-dihydro-10-(4-nitrobenzoyl) -4h-furo[2,3-e]pyrrolo[1,2-a][1,4]diazepine Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C(OC=C2)=C2CN2C=CC=C2C1 AJTFSJMWEFZRFS-UHFFFAOYSA-N 0.000 description 3
- MDVYGZYIPAJDKW-UHFFFAOYSA-N 9,10-dihydro-4h-pyrrolo[1,2-a]thieno[2,3-e][1,4]diazepine Chemical compound C1N2C=CC=C2CNC2=C1C=CS2 MDVYGZYIPAJDKW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101800001144 Arg-vasopressin Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- CQGRLHBOVUGVEA-UHFFFAOYSA-N OOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOO CQGRLHBOVUGVEA-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 235000019483 Peanut oil Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 3
- 229940122618 Trypsin inhibitor Drugs 0.000 description 3
- 101710162629 Trypsin inhibitor Proteins 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000005567 liquid scintillation counting Methods 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 230000009871 nonspecific binding Effects 0.000 description 3
- 239000000312 peanut oil Substances 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- 230000036581 peripheral resistance Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000000159 protein binding assay Methods 0.000 description 3
- 229910052705 radium Inorganic materials 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 229910052722 tritium Inorganic materials 0.000 description 3
- 238000001665 trituration Methods 0.000 description 3
- 239000002753 trypsin inhibitor Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 2
- JUBVMJIVKRUKMO-UHFFFAOYSA-N (2-chloro-4-nitrophenyl)-(6,7-dihydropyrrolo[2,1-d][1,5]benzodiazepin-5-yl)methanone Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2CC1 JUBVMJIVKRUKMO-UHFFFAOYSA-N 0.000 description 2
- SDOICKDRIPUILZ-UHFFFAOYSA-N (4-amino-3-methylphenyl)-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound C1=C(N)C(C)=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C1 SDOICKDRIPUILZ-UHFFFAOYSA-N 0.000 description 2
- VVHYKPBJZLZDJA-UHFFFAOYSA-N (4-aminophenyl)-(11H-pyrrolo[2,1-c][1,4]benzodiazepin-7-yl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=C2C=NC3=CC=CC=C3CN2C=C1 VVHYKPBJZLZDJA-UHFFFAOYSA-N 0.000 description 2
- FFHYXDLDBNYKRK-UHFFFAOYSA-N (4-aminophenyl)-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CN=C2C1 FFHYXDLDBNYKRK-UHFFFAOYSA-N 0.000 description 2
- LCBKDMJJTCVVGW-UHFFFAOYSA-N (4-aminophenyl)-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)N1C2=CC=CC=C2CN2C(Cl)=CC=C2C1 LCBKDMJJTCVVGW-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YKXXOQJFNJYQGD-UHFFFAOYSA-N 1,2,3,5-tetrahydro-1,5-benzodiazepine-4-thione Chemical compound N1C(=S)CCNC2=CC=CC=C21 YKXXOQJFNJYQGD-UHFFFAOYSA-N 0.000 description 2
- RDIXKKWXMOZKRZ-UHFFFAOYSA-N 1-(2-nitrobenzoyl)pyrrole-2-carbaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)N1C(C=O)=CC=C1 RDIXKKWXMOZKRZ-UHFFFAOYSA-N 0.000 description 2
- UQNRTIQURQZGKL-UHFFFAOYSA-N 1-(2-nitrophenyl)pyrrole Chemical compound [O-][N+](=O)C1=CC=CC=C1N1C=CC=C1 UQNRTIQURQZGKL-UHFFFAOYSA-N 0.000 description 2
- HXBMIQJOSHZCFX-UHFFFAOYSA-N 1-(bromomethyl)-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1CBr HXBMIQJOSHZCFX-UHFFFAOYSA-N 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 2
- OSYMOIHZFYBDKJ-UHFFFAOYSA-N 1-methyl-5,6-dihydro-4h-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine Chemical compound C1CNC2=CC=CC=C2N2C(C)=NN=C21 OSYMOIHZFYBDKJ-UHFFFAOYSA-N 0.000 description 2
- POXWDTQUDZUOGP-UHFFFAOYSA-N 1h-1,4-diazepine Chemical compound N1C=CC=NC=C1 POXWDTQUDZUOGP-UHFFFAOYSA-N 0.000 description 2
- BETKMRLCWIABNI-UHFFFAOYSA-N 2,3-dichloro-n-[2,5-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(C(=O)NC=2C(=CC(=C(Cl)C=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1Cl BETKMRLCWIABNI-UHFFFAOYSA-N 0.000 description 2
- YBONBWJSFMTXLE-UHFFFAOYSA-N 2,3-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(Cl)=C1Cl YBONBWJSFMTXLE-UHFFFAOYSA-N 0.000 description 2
- BYXWXIOJFMTXEN-UHFFFAOYSA-N 2,4-dichloro-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 BYXWXIOJFMTXEN-UHFFFAOYSA-N 0.000 description 2
- QJUIBLKMWVDTSN-UHFFFAOYSA-N 2,4-dichloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 QJUIBLKMWVDTSN-UHFFFAOYSA-N 0.000 description 2
- GQZYIPXFBAZUGM-UHFFFAOYSA-N 2,4-dimethyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound CC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 GQZYIPXFBAZUGM-UHFFFAOYSA-N 0.000 description 2
- LYSVAHTZUZHUDJ-UHFFFAOYSA-N 2-(2-methylphenyl)-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 LYSVAHTZUZHUDJ-UHFFFAOYSA-N 0.000 description 2
- FKMIBYMTHOJWCY-UHFFFAOYSA-N 2-(2-methylphenyl)acetyl chloride Chemical compound CC1=CC=CC=C1CC(Cl)=O FKMIBYMTHOJWCY-UHFFFAOYSA-N 0.000 description 2
- BUELHUNWKPRRSN-UHFFFAOYSA-N 2-(2-methylthiophen-3-yl)-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]acetamide Chemical compound S1C=CC(CC(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)=C1C BUELHUNWKPRRSN-UHFFFAOYSA-N 0.000 description 2
- MXIUWSYTQJLIKE-UHFFFAOYSA-N 2-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=CC=C1C(Cl)=O MXIUWSYTQJLIKE-UHFFFAOYSA-N 0.000 description 2
- XBOBDPGEUBQXJJ-UHFFFAOYSA-N 2-chloro-4-[(2,5-dichlorobenzoyl)amino]benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC=C1NC(=O)C1=CC(Cl)=CC=C1Cl XBOBDPGEUBQXJJ-UHFFFAOYSA-N 0.000 description 2
- RZPOBZFSSJQQPZ-UHFFFAOYSA-N 2-chloro-4-[(5-fluoro-2-methylbenzoyl)amino]benzoyl chloride Chemical compound CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(Cl)=O)C(Cl)=C1 RZPOBZFSSJQQPZ-UHFFFAOYSA-N 0.000 description 2
- QWSQRLOMVHQSIQ-UHFFFAOYSA-N 2-chloro-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 QWSQRLOMVHQSIQ-UHFFFAOYSA-N 0.000 description 2
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
- GFRIXXNFAZZDRL-UHFFFAOYSA-N 2-methoxy-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 GFRIXXNFAZZDRL-UHFFFAOYSA-N 0.000 description 2
- CBQIZNKASHVTEP-UHFFFAOYSA-N 2-phenyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]acetamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=CC=1NC(=O)CC1=CC=CC=C1 CBQIZNKASHVTEP-UHFFFAOYSA-N 0.000 description 2
- PWURRRRGLCVBMX-UHFFFAOYSA-N 3-methoxy-4-nitrobenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1[N+]([O-])=O PWURRRRGLCVBMX-UHFFFAOYSA-N 0.000 description 2
- CCPUOOUROHGAOD-UHFFFAOYSA-N 3-methoxy-4-nitrobenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC=C1[N+]([O-])=O CCPUOOUROHGAOD-UHFFFAOYSA-N 0.000 description 2
- JEWUKQJPONYAKF-UHFFFAOYSA-N 4,10-dihydro-9h-furo[2,3-e]pyrrolo[1,2-a][1,4]diazepin-9-one Chemical compound C1N2C=CC=C2C(=O)NC2=C1C=CO2 JEWUKQJPONYAKF-UHFFFAOYSA-N 0.000 description 2
- KZRUYLDWZOEGNB-UHFFFAOYSA-N 4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepin-5-yl-(4-nitrophenyl)methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2CN2N=CC=C2C1 KZRUYLDWZOEGNB-UHFFFAOYSA-N 0.000 description 2
- RFOUCJKKZOCDCQ-UHFFFAOYSA-N 4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 RFOUCJKKZOCDCQ-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- OUQQVGFUUJNRNZ-UHFFFAOYSA-N 4h-pyrazolo[5,1-c][1,4]benzodiazepine Chemical compound C1N=C2C=CC=CC2=CN2N=CC=C12 OUQQVGFUUJNRNZ-UHFFFAOYSA-N 0.000 description 2
- HBAQRSDZSVESSF-UHFFFAOYSA-N 5-fluoro-2-methylbenzoyl chloride Chemical compound CC1=CC=C(F)C=C1C(Cl)=O HBAQRSDZSVESSF-UHFFFAOYSA-N 0.000 description 2
- QJOVDCSUVJCAEC-UHFFFAOYSA-N 5-oxo-4,5-dihydropyrrolo[1,2-a]thieno[3,2-e][1,4]diazepine Chemical compound O=C1NC2=CCSC2=CN2C=CC=C12 QJOVDCSUVJCAEC-UHFFFAOYSA-N 0.000 description 2
- KZUIZMXZHNIGLO-UHFFFAOYSA-N 6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl-(3-methyl-4-nitrophenyl)methanone Chemical compound C1=C([N+]([O-])=O)C(C)=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C1 KZUIZMXZHNIGLO-UHFFFAOYSA-N 0.000 description 2
- SHRCCRVDDUGPRJ-UHFFFAOYSA-N 6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl-(4-nitrophenyl)methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 SHRCCRVDDUGPRJ-UHFFFAOYSA-N 0.000 description 2
- OMXRYYPDXHPHQN-UHFFFAOYSA-N 7h-thieno[2,3-e][1,4]diazepine Chemical compound C1=CN=CC2=CCSC2=N1 OMXRYYPDXHPHQN-UHFFFAOYSA-N 0.000 description 2
- LIUMNBVCHBTLKH-UHFFFAOYSA-N 7h-thieno[3,2-e][1,4]diazepine Chemical compound N1=CC=NC2=CCSC2=C1 LIUMNBVCHBTLKH-UHFFFAOYSA-N 0.000 description 2
- LNKWOQQGZQOPAY-UHFFFAOYSA-N 9,10-dihydro-10-(4-aminobenzoyl)-4h-furo-[2,3-e]pyrrolo[1,2-a][1,4]diazepine Chemical compound C1=CC(N)=CC=C1C(=O)N1C(OC=C2)=C2CN2C=CC=C2C1 LNKWOQQGZQOPAY-UHFFFAOYSA-N 0.000 description 2
- WNEZIWPXYWMZFL-UHFFFAOYSA-N 9,10-dihydro-10-(4-nitrobenzoyl)-4h-pyrrolo-[1,2-a]thieno[2,3-e][1,4]-diazepine Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C(SC=C2)=C2CN2C=CC=C2C1 WNEZIWPXYWMZFL-UHFFFAOYSA-N 0.000 description 2
- BBOWZLYUGCVYLV-UHFFFAOYSA-N 9-oxo-9,10-dihydro-4h-pyrrolo[1,2-a]thieno[2,3-e][1,4]diazepin Chemical compound C1N2C=CC=C2C(=O)NC2=C1C=CS2 BBOWZLYUGCVYLV-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- BFMBHUBTGOWJHI-UHFFFAOYSA-N CC1=C(C=CC(=C1)C(=O)C2=C3C=NC4=CC=CC=C4CN3C=C2)N Chemical compound CC1=C(C=CC(=C1)C(=O)C2=C3C=NC4=CC=CC=C4CN3C=C2)N BFMBHUBTGOWJHI-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021036 Hyponatraemia Diseases 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 2
- DTAFLBZLAZYRDX-UHFFFAOYSA-N OOOOOO Chemical compound OOOOOO DTAFLBZLAZYRDX-UHFFFAOYSA-N 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 102400000050 Oxytocin Human genes 0.000 description 2
- 101800000989 Oxytocin Proteins 0.000 description 2
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 2
- 102000004279 Oxytocin receptors Human genes 0.000 description 2
- 108090000876 Oxytocin receptors Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 239000007825 activation reagent Substances 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000005605 benzo group Chemical group 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- PNZXMIKHJXIPEK-UHFFFAOYSA-N cyclohexanecarboxamide Chemical compound NC(=O)C1CCCCC1 PNZXMIKHJXIPEK-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- LWJYMKDMGMOTSB-UHFFFAOYSA-L dichlorotin;hydrate Chemical compound O.Cl[Sn]Cl LWJYMKDMGMOTSB-UHFFFAOYSA-L 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- SFDPUCNVBPEHAY-UHFFFAOYSA-N ethyl 3-[(2-formylpyrrol-1-yl)methyl]-4-nitrobenzoate Chemical compound CCOC(=O)C1=CC=C([N+]([O-])=O)C(CN2C(=CC=C2)C=O)=C1 SFDPUCNVBPEHAY-UHFFFAOYSA-N 0.000 description 2
- RECWKGFLXTXYQR-UHFFFAOYSA-N ethyl 4-[(2-methylbenzoyl)amino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=CC=C1C RECWKGFLXTXYQR-UHFFFAOYSA-N 0.000 description 2
- CTWISIWZEJOBPA-UHFFFAOYSA-N ethyl 6,11-dihydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxylate Chemical compound C1NC2=CC(C(=O)OCC)=CC=C2CN2C=CC=C21 CTWISIWZEJOBPA-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- MFFXVVHUKRKXCI-UHFFFAOYSA-N ethyl iodoacetate Chemical compound CCOC(=O)CI MFFXVVHUKRKXCI-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- XZBIXDPGRMLSTC-UHFFFAOYSA-N formohydrazide Chemical compound NNC=O XZBIXDPGRMLSTC-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- YOSMBKCKYMYISK-UHFFFAOYSA-N methyl 4-[2-(2-chlorophenyl)-2-oxoethyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CC(=O)C1=CC=CC=C1Cl YOSMBKCKYMYISK-UHFFFAOYSA-N 0.000 description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- PXKLJPXPZFUMIL-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1C PXKLJPXPZFUMIL-UHFFFAOYSA-N 0.000 description 2
- MBSXPMCPDSEULX-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]-2-methylthiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C)=C1C MBSXPMCPDSEULX-UHFFFAOYSA-N 0.000 description 2
- ZJVNUFWEXKDOOI-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)C=C1 ZJVNUFWEXKDOOI-UHFFFAOYSA-N 0.000 description 2
- 230000011224 negative regulation of urine volume Effects 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 2
- 229910052701 rubidium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000008259 solid foam Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- LXEJRKJRKIFVNY-UHFFFAOYSA-N terephthaloyl chloride Chemical compound ClC(=O)C1=CC=C(C(Cl)=O)C=C1 LXEJRKJRKIFVNY-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- GZNAASVAJNXPPW-UHFFFAOYSA-M tin(4+) chloride dihydrate Chemical compound O.O.[Cl-].[Sn+4] GZNAASVAJNXPPW-UHFFFAOYSA-M 0.000 description 2
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Substances O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- SOCAXRLFGRNEPK-IFZYUDKTSA-N (1r,3s,5r)-2-n-[1-carbamoyl-5-(cyanomethoxy)indol-3-yl]-3-n-[(3-chloro-2-fluorophenyl)methyl]-2-azabicyclo[3.1.0]hexane-2,3-dicarboxamide Chemical compound O=C([C@@H]1C[C@H]2C[C@H]2N1C(=O)NC1=CN(C2=CC=C(OCC#N)C=C21)C(=O)N)NCC1=CC=CC(Cl)=C1F SOCAXRLFGRNEPK-IFZYUDKTSA-N 0.000 description 1
- DFRJZGXYXHALBY-UHFFFAOYSA-N (2-aminophenyl)-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-6-yl)methanone Chemical compound NC1=C(C(=O)N2CCC=3N(C4=C2C=CC=C4)C=NN3)C=CC=C1 DFRJZGXYXHALBY-UHFFFAOYSA-N 0.000 description 1
- QGQLYAQLLMMPIN-UHFFFAOYSA-N (2-aminophenyl)-(4-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-2,6,10,12-tetraen-8-yl)methanone Chemical compound NC1=C(C(=O)N2CC=3N(C=C4C2=CCS4)C=CC=3)C=CC=C1 QGQLYAQLLMMPIN-UHFFFAOYSA-N 0.000 description 1
- FLUFYQSCLSTLQQ-UHFFFAOYSA-N (2-chloro-3-nitrophenyl)-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C1Cl FLUFYQSCLSTLQQ-UHFFFAOYSA-N 0.000 description 1
- HOEDVRAGYZCVOD-UHFFFAOYSA-N (2-chloro-4-nitrophenyl)-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2CN2N=CC=C2C1 HOEDVRAGYZCVOD-UHFFFAOYSA-N 0.000 description 1
- UTVCMZLSXVPFCG-UHFFFAOYSA-N (2-cyanoanilino) acetate Chemical compound CC(=O)ONC1=CC=CC=C1C#N UTVCMZLSXVPFCG-UHFFFAOYSA-N 0.000 description 1
- AFPLQPAYSMUDIT-UHFFFAOYSA-N (3-methyl-4-nitrophenyl)-(11H-pyrrolo[2,1-c][1,4]benzodiazepin-7-yl)methanone Chemical compound CC=1C=C(C(=O)C=2C=CN3C=2C=NC2=C(C3)C=CC=C2)C=CC=1[N+](=O)[O-] AFPLQPAYSMUDIT-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- CMMKGAWBFUYUEY-UHFFFAOYSA-N (4-amino-2-chlorophenyl)-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound ClC1=CC(N)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 CMMKGAWBFUYUEY-UHFFFAOYSA-N 0.000 description 1
- IBHGYOXXJWZYQV-UHFFFAOYSA-N (4-aminophenyl)-(10H-imidazo[2,1-c][1,4]benzodiazepin-2-yl)methanone Chemical compound NC1=CC=C(C(=O)C=2N=C3C=NC4=C(CN3C=2)C=CC=C4)C=C1 IBHGYOXXJWZYQV-UHFFFAOYSA-N 0.000 description 1
- YYNGAEBOOQBJNV-UHFFFAOYSA-N (4-aminophenyl)-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepin-5-yl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)N1C2=CC=CC=C2CN2N=CC=C2C1 YYNGAEBOOQBJNV-UHFFFAOYSA-N 0.000 description 1
- GRSZMTPTHIDMFP-UHFFFAOYSA-N (4-nitrophenyl)-(11H-pyrrolo[2,1-c][1,4]benzodiazepin-7-yl)methanone Chemical compound [N+](=O)([O-])C1=CC=C(C(=O)C=2C=CN3C=2C=NC2=C(C3)C=CC=C2)C=C1 GRSZMTPTHIDMFP-UHFFFAOYSA-N 0.000 description 1
- NCLFSGXGSMWKDV-UHFFFAOYSA-N (4-nitrophenyl)-(4h-pyrrolo[1,2-a]quinoxalin-5-yl)methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2C1 NCLFSGXGSMWKDV-UHFFFAOYSA-N 0.000 description 1
- HGRWHBQLRXWSLV-DEOSSOPVSA-N (4s)-3'-(3,6-dihydro-2h-pyran-5-yl)-1'-fluoro-7'-(3-fluoropyridin-2-yl)spiro[5h-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine Chemical compound C1OC(N)=N[C@]21C1=CC(C=3COCCC=3)=NC(F)=C1OC1=CC=C(C=3C(=CC=CN=3)F)C=C12 HGRWHBQLRXWSLV-DEOSSOPVSA-N 0.000 description 1
- YDCUQJVYYWANPZ-UHFFFAOYSA-N 1,2,4,5-tetrahydro-1,4-benzodiazepin-3-one Chemical compound C1NC(=O)CNC2=CC=CC=C21 YDCUQJVYYWANPZ-UHFFFAOYSA-N 0.000 description 1
- YZPAKBGVJIVPEU-UHFFFAOYSA-N 1,2-benzodiazepin-6-one Chemical compound N1=NC=CC=C2C(=O)C=CC=C21 YZPAKBGVJIVPEU-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- DVLRNCUAXRYSPF-UHFFFAOYSA-N 1,3,4,5,5a,6-hexahydro-1,5-benzodiazepin-2-one Chemical compound N1C(CCNC2C1=CC=CC2)=O DVLRNCUAXRYSPF-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- PURSZYWBIQIANP-UHFFFAOYSA-N 1-(bromomethyl)-2-chlorobenzene Chemical compound ClC1=CC=CC=C1CBr PURSZYWBIQIANP-UHFFFAOYSA-N 0.000 description 1
- WHFKDRFUKGSXHG-UHFFFAOYSA-N 1-[(2-nitrophenyl)methyl]imidazole-2-carbaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1CN1C(C=O)=NC=C1 WHFKDRFUKGSXHG-UHFFFAOYSA-N 0.000 description 1
- AKFAPUIPEQSHJL-UHFFFAOYSA-N 1-[(2-nitrophenyl)methyl]pyrrole-2-carbaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1CN1C(C=O)=CC=C1 AKFAPUIPEQSHJL-UHFFFAOYSA-N 0.000 description 1
- PWKNBLFSJAVFAB-UHFFFAOYSA-N 1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1F PWKNBLFSJAVFAB-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- HRXWEEMUEVOXNA-UHFFFAOYSA-N 1h-pyrazolo[5,1-c][1,4]benzodiazepine Chemical compound N1=C2C=CC=CC2=CN2NC=CC2=C1 HRXWEEMUEVOXNA-UHFFFAOYSA-N 0.000 description 1
- QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 1
- TVZDIFXOIOIPJG-UHFFFAOYSA-N 2,3,4-trichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1Cl TVZDIFXOIOIPJG-UHFFFAOYSA-N 0.000 description 1
- HAKGMEWPOUSNDK-UHFFFAOYSA-N 2,3,5-trichloro-n-[2-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=C(Cl)C(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)Cl)=C1 HAKGMEWPOUSNDK-UHFFFAOYSA-N 0.000 description 1
- ZQSKNLZUONIXDK-UHFFFAOYSA-N 2,3-dichloro-n-[2,3-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(C(=O)NC=2C(=C(Cl)C(C(=O)N3C4=CC=CC=C4CN4C=CC=C4C3)=CC=2)Cl)=C1Cl ZQSKNLZUONIXDK-UHFFFAOYSA-N 0.000 description 1
- DVJBMSQLDPKKMF-UHFFFAOYSA-N 2,3-dichloro-n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=CC=C1NC(=O)C1=CC=CC(Cl)=C1Cl DVJBMSQLDPKKMF-UHFFFAOYSA-N 0.000 description 1
- CGEDSMKNALNYHU-UHFFFAOYSA-N 2,3-dichloro-n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4N4C=CC=C4CC3)=CC=2)=C1Cl CGEDSMKNALNYHU-UHFFFAOYSA-N 0.000 description 1
- JIHSXWSSOOHYBY-UHFFFAOYSA-N 2,3-dichloro-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)=C1Cl JIHSXWSSOOHYBY-UHFFFAOYSA-N 0.000 description 1
- KZKYRHRAVGWEAV-UHFFFAOYSA-N 2,3-dichlorobenzamide Chemical compound NC(=O)C1=CC=CC(Cl)=C1Cl KZKYRHRAVGWEAV-UHFFFAOYSA-N 0.000 description 1
- CDCFERWURRNLLA-UHFFFAOYSA-N 2,3-difluorobenzoyl chloride Chemical compound FC1=CC=CC(C(Cl)=O)=C1F CDCFERWURRNLLA-UHFFFAOYSA-N 0.000 description 1
- UKGPPUFJOCIPKM-UHFFFAOYSA-N 2,3-dimethyl-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)=C1C UKGPPUFJOCIPKM-UHFFFAOYSA-N 0.000 description 1
- FVWXCDZOWHOHEY-UHFFFAOYSA-N 2,3-dimethyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)=C1C FVWXCDZOWHOHEY-UHFFFAOYSA-N 0.000 description 1
- WFNKMVDATNLZBX-UHFFFAOYSA-N 2,3-dimethylbenzoyl chloride Chemical compound CC1=CC=CC(C(Cl)=O)=C1C WFNKMVDATNLZBX-UHFFFAOYSA-N 0.000 description 1
- IRSVDHPYXFLLDS-UHFFFAOYSA-N 2,4-dichloro-1-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1Cl IRSVDHPYXFLLDS-UHFFFAOYSA-N 0.000 description 1
- XWOHSVOSWMZBIG-UHFFFAOYSA-N 2,4-dichloro-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 XWOHSVOSWMZBIG-UHFFFAOYSA-N 0.000 description 1
- HOOBDBULWRCVGC-UHFFFAOYSA-N 2,4-dichloro-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 HOOBDBULWRCVGC-UHFFFAOYSA-N 0.000 description 1
- PUURBLHXBBZAAZ-UHFFFAOYSA-N 2,4-dichloro-n-[2,3-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC(C(=C1Cl)Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 PUURBLHXBBZAAZ-UHFFFAOYSA-N 0.000 description 1
- LIYNNKSVHQFBKN-UHFFFAOYSA-N 2,4-dichloro-n-[2,5-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC(Cl)=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl LIYNNKSVHQFBKN-UHFFFAOYSA-N 0.000 description 1
- HSJGPDZTWVYWSQ-UHFFFAOYSA-N 2,4-dichloro-n-[2,5-dichloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC(Cl)=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1Cl HSJGPDZTWVYWSQ-UHFFFAOYSA-N 0.000 description 1
- VTPTVNXJOSTNTQ-UHFFFAOYSA-N 2,4-dichloro-n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2CC1 VTPTVNXJOSTNTQ-UHFFFAOYSA-N 0.000 description 1
- IPEWFURUDXCEOG-UHFFFAOYSA-N 2,4-dichloro-n-[4-(1-chloro-4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound C12=CC=CC=C2N2C(Cl)=CC=C2CN1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C=C1Cl IPEWFURUDXCEOG-UHFFFAOYSA-N 0.000 description 1
- PQOVUMBXYPCTDD-UHFFFAOYSA-N 2,4-dichloro-n-[4-(1-methyl-4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]benzamide Chemical compound C12=CC=CC=C2N2C(C)=NN=C2CCN1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C=C1Cl PQOVUMBXYPCTDD-UHFFFAOYSA-N 0.000 description 1
- GZUMSZPYJDEDTG-UHFFFAOYSA-N 2,4-dichloro-n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 GZUMSZPYJDEDTG-UHFFFAOYSA-N 0.000 description 1
- GEYYOAZTTBBLAA-UHFFFAOYSA-N 2,4-dichloro-n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 GEYYOAZTTBBLAA-UHFFFAOYSA-N 0.000 description 1
- OTKYTKHGFAWSMU-UHFFFAOYSA-N 2,4-dichloro-n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 OTKYTKHGFAWSMU-UHFFFAOYSA-N 0.000 description 1
- QBSUBGCHTFCLQF-UHFFFAOYSA-N 2,4-dichloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-n-[(dimethylamino)methyl]benzamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=CC=1N(CN(C)C)C(=O)C1=CC=C(Cl)C=C1Cl QBSUBGCHTFCLQF-UHFFFAOYSA-N 0.000 description 1
- GNSUQNHRPQRSRS-UHFFFAOYSA-N 2,4-dichloro-n-[4-(6,7-dihydropyrrolo[2,1-d][1,5]benzodiazepine-5-carbonyl)-3-methoxyphenyl]benzamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C(OC)=CC=1NC(=O)C1=CC=C(Cl)C=C1Cl GNSUQNHRPQRSRS-UHFFFAOYSA-N 0.000 description 1
- HITKBAOSWSBBOT-UHFFFAOYSA-N 2,4-dichloro-n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound C12=CC=CC=C2CN2C(Cl)=CC=C2CN1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C=C1Cl HITKBAOSWSBBOT-UHFFFAOYSA-N 0.000 description 1
- OLDAYGVIHARNTC-UHFFFAOYSA-N 2,4-dichloro-n-[4-[9-(2,2,2-trichloroacetyl)-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl]phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C(C(=O)C(Cl)(Cl)Cl)=CC=C3C2)C=C1 OLDAYGVIHARNTC-UHFFFAOYSA-N 0.000 description 1
- XXFUNTSOBHSMBU-UHFFFAOYSA-N 2,4-dichlorobenzamide Chemical compound NC(=O)C1=CC=C(Cl)C=C1Cl XXFUNTSOBHSMBU-UHFFFAOYSA-N 0.000 description 1
- KTXFXDMDYZIXSJ-UHFFFAOYSA-N 2,4-difluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C=C1F KTXFXDMDYZIXSJ-UHFFFAOYSA-N 0.000 description 1
- MQHWKEKSLIEYIC-UHFFFAOYSA-N 2,4-dimethoxy-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound COC1=CC(OC)=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 MQHWKEKSLIEYIC-UHFFFAOYSA-N 0.000 description 1
- FUAGKYRQCTWFMT-UHFFFAOYSA-N 2,4-dimethoxy-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound COC1=CC(OC)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 FUAGKYRQCTWFMT-UHFFFAOYSA-N 0.000 description 1
- BJWXMCRVTCMQMY-UHFFFAOYSA-N 2,4-dimethyl-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound CC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 BJWXMCRVTCMQMY-UHFFFAOYSA-N 0.000 description 1
- DZNYNDKHBLNAAT-UHFFFAOYSA-N 2,5-dichloro-N-[4-(4-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-2,6,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound S1CC=C2N(CC=3N(C=C21)C=CC=3)C(=O)C1=CC=C(C=C1)NC(C1=C(C=CC(=C1)Cl)Cl)=O DZNYNDKHBLNAAT-UHFFFAOYSA-N 0.000 description 1
- SGCSUFMSBNPKLB-UHFFFAOYSA-N 2,5-dichloro-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=C(Cl)C(C(=O)NC=2C=CC(=CC=2)C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)=C1 SGCSUFMSBNPKLB-UHFFFAOYSA-N 0.000 description 1
- TWXNIXYWAXVZPZ-UHFFFAOYSA-N 2,5-dichloro-n-[2,5-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=C(Cl)C(C(=O)NC=2C(=CC(=C(Cl)C=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1 TWXNIXYWAXVZPZ-UHFFFAOYSA-N 0.000 description 1
- DIIRSTHBOGTGAV-UHFFFAOYSA-N 2,5-dichloro-n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=C(Cl)C(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1 DIIRSTHBOGTGAV-UHFFFAOYSA-N 0.000 description 1
- WONXANQNKVCQQF-UHFFFAOYSA-N 2,5-dichloro-n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=C(Cl)C(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)=C1 WONXANQNKVCQQF-UHFFFAOYSA-N 0.000 description 1
- ANTGQBOLVPKMTG-UHFFFAOYSA-N 2,5-dichloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]benzamide Chemical compound CC1=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=CC=C1NC(=O)C1=CC(Cl)=CC=C1Cl ANTGQBOLVPKMTG-UHFFFAOYSA-N 0.000 description 1
- PAHRLWYERIQMFZ-UHFFFAOYSA-N 2,5-dichloro-n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=C(Cl)C(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)=C1 PAHRLWYERIQMFZ-UHFFFAOYSA-N 0.000 description 1
- CPHHKZJXHZUHRA-UHFFFAOYSA-N 2,5-dichloro-n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound C12=CC=CC=C2CN2C(Cl)=CC=C2CN1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC(Cl)=CC=C1Cl CPHHKZJXHZUHRA-UHFFFAOYSA-N 0.000 description 1
- BXCOSWRSIISQSL-UHFFFAOYSA-N 2,5-dichlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(Cl)C(S(Cl)(=O)=O)=C1 BXCOSWRSIISQSL-UHFFFAOYSA-N 0.000 description 1
- STWHSIHNQQYQAY-UHFFFAOYSA-N 2,6-dichloro-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 STWHSIHNQQYQAY-UHFFFAOYSA-N 0.000 description 1
- WVGLRVISGLDXFH-UHFFFAOYSA-N 2,6-dichloro-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 WVGLRVISGLDXFH-UHFFFAOYSA-N 0.000 description 1
- WJIPSVUPXORQOY-UHFFFAOYSA-N 2,6-dichloro-n-[2-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)=CC=C1NC(=O)C1=C(Cl)C=CC=C1Cl WJIPSVUPXORQOY-UHFFFAOYSA-N 0.000 description 1
- BAJKWWPUHDBZEJ-UHFFFAOYSA-N 2,6-dichloro-n-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 BAJKWWPUHDBZEJ-UHFFFAOYSA-N 0.000 description 1
- BTCDCVZHCNFKJW-UHFFFAOYSA-N 2,6-dichloro-n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 BTCDCVZHCNFKJW-UHFFFAOYSA-N 0.000 description 1
- SGAHTBBRVVZDIB-UHFFFAOYSA-N 2,6-dichloro-n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 SGAHTBBRVVZDIB-UHFFFAOYSA-N 0.000 description 1
- ATUQWJWHOHWWKY-UHFFFAOYSA-N 2,6-dichloro-n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 ATUQWJWHOHWWKY-UHFFFAOYSA-N 0.000 description 1
- SDIZVTFARAPBFM-UHFFFAOYSA-N 2,6-dichloro-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 SDIZVTFARAPBFM-UHFFFAOYSA-N 0.000 description 1
- LUIHWONNADEXHA-UHFFFAOYSA-N 2,6-dichloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 LUIHWONNADEXHA-UHFFFAOYSA-N 0.000 description 1
- KPKBZQRUDHQLBF-UHFFFAOYSA-N 2,6-dichloro-n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC(Cl)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1 KPKBZQRUDHQLBF-UHFFFAOYSA-N 0.000 description 1
- IZCBPJWTNNJVSZ-UHFFFAOYSA-N 2,6-dimethoxy-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound COC1=CC=CC(OC)=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 IZCBPJWTNNJVSZ-UHFFFAOYSA-N 0.000 description 1
- ASXOYPJUHLIMLD-UHFFFAOYSA-N 2,6-dimethoxy-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound COC1=CC=CC(OC)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 ASXOYPJUHLIMLD-UHFFFAOYSA-N 0.000 description 1
- NXDXMSTXCYCUGG-UHFFFAOYSA-N 2,6-dimethylbenzamide Chemical compound CC1=CC=CC(C)=C1C(N)=O NXDXMSTXCYCUGG-UHFFFAOYSA-N 0.000 description 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 1
- MSSMCFBLIOVFAF-UHFFFAOYSA-N 2-(2-acetylhydrazinyl)-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-phenylacetamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=CC=1NC(=O)C(NNC(=O)C)C1=CC=CC=C1 MSSMCFBLIOVFAF-UHFFFAOYSA-N 0.000 description 1
- VHFLVCZKSJSNIK-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]acetamide Chemical compound ClC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 VHFLVCZKSJSNIK-UHFFFAOYSA-N 0.000 description 1
- CBFOOZOLKDIORZ-UHFFFAOYSA-N 2-(2-chlorophenyl)-n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]acetamide Chemical compound ClC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 CBFOOZOLKDIORZ-UHFFFAOYSA-N 0.000 description 1
- RFDQASOHYJMWOT-UHFFFAOYSA-N 2-(2-chlorophenyl)-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]acetamide Chemical compound ClC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 RFDQASOHYJMWOT-UHFFFAOYSA-N 0.000 description 1
- IUJAAIZKRJJZGQ-UHFFFAOYSA-N 2-(2-chlorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1Cl IUJAAIZKRJJZGQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- XXKDCHNXDFIDLN-UHFFFAOYSA-N 2-(2-methoxyphenyl)-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]acetamide Chemical compound COC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 XXKDCHNXDFIDLN-UHFFFAOYSA-N 0.000 description 1
- VKGFAPWPQZONAF-UHFFFAOYSA-N 2-(2-methylphenyl)-N-[4-(4-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-2,6,10,12-tetraene-8-carbonyl)phenyl]acetamide Chemical compound S1CC=C2N(CC=3N(C=C21)C=CC=3)C(=O)C1=CC=C(C=C1)NC(CC1=C(C=CC=C1)C)=O VKGFAPWPQZONAF-UHFFFAOYSA-N 0.000 description 1
- VEVPMOOZOOPAIQ-UHFFFAOYSA-N 2-(2-methylphenyl)-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 VEVPMOOZOOPAIQ-UHFFFAOYSA-N 0.000 description 1
- RZWGTXHSYZGXKF-UHFFFAOYSA-N 2-(2-methylphenyl)acetic acid Chemical compound CC1=CC=CC=C1CC(O)=O RZWGTXHSYZGXKF-UHFFFAOYSA-N 0.000 description 1
- AZHWHRUDQYYFGR-UHFFFAOYSA-N 2-(2-methylthiophen-3-yl)-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]acetamide Chemical compound S1C=CC(CC(=O)NC=2C=CC(=CC=2)C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)=C1C AZHWHRUDQYYFGR-UHFFFAOYSA-N 0.000 description 1
- MFVMWBIORCNCNB-UHFFFAOYSA-N 2-(3-methyl-1-benzothiophen-2-yl)acetic acid Chemical compound C1=CC=C2C(C)=C(CC(O)=O)SC2=C1 MFVMWBIORCNCNB-UHFFFAOYSA-N 0.000 description 1
- FKASAVXZZLJTNX-UHFFFAOYSA-N 2-(dimethylamino)acetic acid;hydrochloride Chemical compound [Cl-].C[NH+](C)CC(O)=O FKASAVXZZLJTNX-UHFFFAOYSA-N 0.000 description 1
- WDJWIEJTUWSOIM-UHFFFAOYSA-N 2-(sulfanylmethyl)benzamide Chemical compound NC(=O)C1=CC=CC=C1CS WDJWIEJTUWSOIM-UHFFFAOYSA-N 0.000 description 1
- FBRJYBGLCHWYOE-UHFFFAOYSA-N 2-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(F)(F)F FBRJYBGLCHWYOE-UHFFFAOYSA-N 0.000 description 1
- 125000002995 2-(trifluoromethyl)benzoyl group Chemical group FC(C1=C(C(=O)*)C=CC=C1)(F)F 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- NPHULPIAPWNOOH-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2,3-dihydroindol-1-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCC2=CC=CC=C12 NPHULPIAPWNOOH-UHFFFAOYSA-N 0.000 description 1
- OBCUSTCTKLTMBX-UHFFFAOYSA-N 2-acetyloxy-2-phenylacetic acid Chemical compound CC(=O)OC(C(O)=O)C1=CC=CC=C1 OBCUSTCTKLTMBX-UHFFFAOYSA-N 0.000 description 1
- JXQKUHCBNVNRSV-UHFFFAOYSA-N 2-aminoacetamide;dihydrochloride Chemical compound Cl.Cl.NCC(N)=O JXQKUHCBNVNRSV-UHFFFAOYSA-N 0.000 description 1
- HLCPWBZNUKCSBN-UHFFFAOYSA-N 2-aminobenzonitrile Chemical compound NC1=CC=CC=C1C#N HLCPWBZNUKCSBN-UHFFFAOYSA-N 0.000 description 1
- GDZIUPSVNFJQPJ-UHFFFAOYSA-N 2-bromo-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound BrC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 GDZIUPSVNFJQPJ-UHFFFAOYSA-N 0.000 description 1
- FGEAOSXMQZWHIQ-UHFFFAOYSA-N 2-chloro-2-phenylacetyl chloride Chemical compound ClC(=O)C(Cl)C1=CC=CC=C1 FGEAOSXMQZWHIQ-UHFFFAOYSA-N 0.000 description 1
- SSPSZTCQFVQVFU-UHFFFAOYSA-N 2-chloro-4-[(2,3-dichlorobenzoyl)amino]benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC=C1NC(=O)C1=CC=CC(Cl)=C1Cl SSPSZTCQFVQVFU-UHFFFAOYSA-N 0.000 description 1
- WTAUZNDCNPQLEZ-UHFFFAOYSA-N 2-chloro-4-[(2,3-dimethylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=CC(C(=O)NC=2C=C(Cl)C(C(O)=O)=CC=2)=C1C WTAUZNDCNPQLEZ-UHFFFAOYSA-N 0.000 description 1
- CFFMQMUQMIQABP-UHFFFAOYSA-N 2-chloro-4-[(2,4-dichlorobenzoyl)amino]benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC=C1NC(=O)C1=CC=C(Cl)C=C1Cl CFFMQMUQMIQABP-UHFFFAOYSA-N 0.000 description 1
- GIMJSTJDIHVYLC-UHFFFAOYSA-N 2-chloro-4-[(2,5-difluorobenzoyl)amino]benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC=C1NC(=O)C1=CC(F)=CC=C1F GIMJSTJDIHVYLC-UHFFFAOYSA-N 0.000 description 1
- MCNJIHRBBVGPHP-UHFFFAOYSA-N 2-chloro-4-[(2,5-dimethylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=C(C)C(C(=O)NC=2C=C(Cl)C(C(O)=O)=CC=2)=C1 MCNJIHRBBVGPHP-UHFFFAOYSA-N 0.000 description 1
- AOULTVVIBWRUGQ-UHFFFAOYSA-N 2-chloro-4-[(2-methylbenzoyl)amino]benzoyl chloride Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(Cl)=O)C(Cl)=C1 AOULTVVIBWRUGQ-UHFFFAOYSA-N 0.000 description 1
- YPNGBCGCHDYRTC-UHFFFAOYSA-N 2-chloro-4-[(3-fluorobenzoyl)amino]benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC=C1NC(=O)C1=CC=CC(F)=C1 YPNGBCGCHDYRTC-UHFFFAOYSA-N 0.000 description 1
- AHDPYRJDKSVKNY-UHFFFAOYSA-N 2-chloro-4-methyl-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 AHDPYRJDKSVKNY-UHFFFAOYSA-N 0.000 description 1
- XFLVMDKNSQCGOJ-UHFFFAOYSA-N 2-chloro-4-methyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 XFLVMDKNSQCGOJ-UHFFFAOYSA-N 0.000 description 1
- KOUXXDBSJABGLU-UHFFFAOYSA-N 2-chloro-4-methylbenzamide Chemical compound CC1=CC=C(C(N)=O)C(Cl)=C1 KOUXXDBSJABGLU-UHFFFAOYSA-N 0.000 description 1
- KTHNITVDTYAHFF-UHFFFAOYSA-N 2-chloro-4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C(Cl)=C1 KTHNITVDTYAHFF-UHFFFAOYSA-N 0.000 description 1
- YLCYHIBECQJCQZ-UHFFFAOYSA-N 2-chloro-n-[2,5-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C(Cl)C=C1NC(=O)C1=CC=CC=C1Cl YLCYHIBECQJCQZ-UHFFFAOYSA-N 0.000 description 1
- IYFGYONLOPJRIZ-UHFFFAOYSA-N 2-chloro-n-[2,5-dichloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)=C(Cl)C=C1NC(=O)C1=CC=CC=C1Cl IYFGYONLOPJRIZ-UHFFFAOYSA-N 0.000 description 1
- LEPZLOCKJLJKDP-UHFFFAOYSA-N 2-chloro-n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-4-fluorobenzamide Chemical compound ClC1=CC(F)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl LEPZLOCKJLJKDP-UHFFFAOYSA-N 0.000 description 1
- DHMHINMHPIVZBS-UHFFFAOYSA-N 2-chloro-n-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3,4-dimethoxybenzamide Chemical compound ClC1=C(OC)C(OC)=CC=C1C(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 DHMHINMHPIVZBS-UHFFFAOYSA-N 0.000 description 1
- MGZAEJXRAJXGQL-UHFFFAOYSA-N 2-chloro-n-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-4-fluorobenzamide Chemical compound ClC1=CC(F)=CC=C1C(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 MGZAEJXRAJXGQL-UHFFFAOYSA-N 0.000 description 1
- LOZRBZGCTKYDNN-UHFFFAOYSA-N 2-chloro-n-[4-(1-chloro-4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound C12=CC=CC=C2N2C(Cl)=CC=C2CN1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1Cl LOZRBZGCTKYDNN-UHFFFAOYSA-N 0.000 description 1
- GZJUXTUHYRPOCI-UHFFFAOYSA-N 2-chloro-n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-4-methylbenzamide Chemical compound ClC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 GZJUXTUHYRPOCI-UHFFFAOYSA-N 0.000 description 1
- QCCYJVSUUTXPMP-UHFFFAOYSA-N 2-chloro-n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 QCCYJVSUUTXPMP-UHFFFAOYSA-N 0.000 description 1
- TWPNJELVNQGEFN-UHFFFAOYSA-N 2-chloro-n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-4-methylbenzamide Chemical compound ClC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 TWPNJELVNQGEFN-UHFFFAOYSA-N 0.000 description 1
- MKTNAJVXAZHCEV-UHFFFAOYSA-N 2-chloro-n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-4-methylbenzamide Chemical compound ClC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 MKTNAJVXAZHCEV-UHFFFAOYSA-N 0.000 description 1
- LWPMWFNJCPPEEQ-UHFFFAOYSA-N 2-chloro-n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]benzamide Chemical compound ClC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 LWPMWFNJCPPEEQ-UHFFFAOYSA-N 0.000 description 1
- KXIIKZWYFOMDJV-UHFFFAOYSA-N 2-chloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-4-fluorobenzamide Chemical compound ClC1=CC(F)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 KXIIKZWYFOMDJV-UHFFFAOYSA-N 0.000 description 1
- ZESHUYCLLCTZMV-UHFFFAOYSA-N 2-chloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzenesulfonamide Chemical compound ClC1=CC=CC=C1S(=O)(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 ZESHUYCLLCTZMV-UHFFFAOYSA-N 0.000 description 1
- XZKDADFDBQFKGS-UHFFFAOYSA-N 2-chloro-n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-4-methylbenzamide Chemical compound ClC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1 XZKDADFDBQFKGS-UHFFFAOYSA-N 0.000 description 1
- RBGDLYUEXLWQBZ-UHFFFAOYSA-N 2-chlorobenzamide Chemical compound NC(=O)C1=CC=CC=C1Cl RBGDLYUEXLWQBZ-UHFFFAOYSA-N 0.000 description 1
- ZLGMPMOKIKZJJB-UHFFFAOYSA-N 2-cyclohexyl-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]acetamide Chemical compound C=1C=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=CC=1NC(=O)CC1CCCCC1 ZLGMPMOKIKZJJB-UHFFFAOYSA-N 0.000 description 1
- DKLQJNUJPSHYQG-UHFFFAOYSA-N 2-cyclohexylacetamide Chemical compound NC(=O)CC1CCCCC1 DKLQJNUJPSHYQG-UHFFFAOYSA-N 0.000 description 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- MDKAAWDKKBFSTK-UHFFFAOYSA-N 2-ethoxybenzoyl chloride Chemical compound CCOC1=CC=CC=C1C(Cl)=O MDKAAWDKKBFSTK-UHFFFAOYSA-N 0.000 description 1
- RAAGZOYMEQDCTD-UHFFFAOYSA-N 2-fluorobenzoyl chloride Chemical compound FC1=CC=CC=C1C(Cl)=O RAAGZOYMEQDCTD-UHFFFAOYSA-N 0.000 description 1
- GFCKVCIBMOECRA-UHFFFAOYSA-N 2-methoxy-N-[4-(4-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-2,6,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound S1CC=C2N(CC=3N(C=C21)C=CC=3)C(=O)C1=CC=C(C=C1)NC(C1=C(C=CC=C1)OC)=O GFCKVCIBMOECRA-UHFFFAOYSA-N 0.000 description 1
- QTXHRVSPKPYAME-UHFFFAOYSA-N 2-methoxy-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 QTXHRVSPKPYAME-UHFFFAOYSA-N 0.000 description 1
- ZKKUNNRFBMAFCR-UHFFFAOYSA-N 2-methoxy-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 ZKKUNNRFBMAFCR-UHFFFAOYSA-N 0.000 description 1
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 description 1
- PABICCONINJNIX-UHFFFAOYSA-N 2-methyl-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzenecarbothioamide Chemical compound CC1=CC=CC=C1C(=S)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 PABICCONINJNIX-UHFFFAOYSA-N 0.000 description 1
- TWXRDPUVTJVPQU-UHFFFAOYSA-N 2-methyl-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]furan-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)=C1C TWXRDPUVTJVPQU-UHFFFAOYSA-N 0.000 description 1
- ZZGWMVITPMXZIA-UHFFFAOYSA-N 2-methyl-N-[4-(6-oxa-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]thiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)=C1C ZZGWMVITPMXZIA-UHFFFAOYSA-N 0.000 description 1
- JLNTYQIKCRFFIO-UHFFFAOYSA-N 2-methyl-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]thiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)=C1C JLNTYQIKCRFFIO-UHFFFAOYSA-N 0.000 description 1
- LQWFDPFFSBTEFH-UHFFFAOYSA-N 2-methyl-n-[4-(1-methyl-4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]benzamide Chemical compound C12=CC=CC=C2N2C(C)=NN=C2CCN1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C LQWFDPFFSBTEFH-UHFFFAOYSA-N 0.000 description 1
- KTCQFUJWXZNLDL-UHFFFAOYSA-N 2-methyl-n-[4-(11-oxo-6h-pyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3C(=O)N3C=CC=C3C2)C=C1 KTCQFUJWXZNLDL-UHFFFAOYSA-N 0.000 description 1
- AXSDNZASPOBKIP-UHFFFAOYSA-N 2-methyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]furan-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)=C1C AXSDNZASPOBKIP-UHFFFAOYSA-N 0.000 description 1
- UXWRRFLRCZRCSP-UHFFFAOYSA-N 2-methyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]thiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)=C1C UXWRRFLRCZRCSP-UHFFFAOYSA-N 0.000 description 1
- XXUNIGZDNWWYED-UHFFFAOYSA-N 2-methylbenzamide Chemical compound CC1=CC=CC=C1C(N)=O XXUNIGZDNWWYED-UHFFFAOYSA-N 0.000 description 1
- NTNUPCREDHXJEL-UHFFFAOYSA-N 2-methylbenzene-1,4-dicarbonyl chloride Chemical compound CC1=CC(C(Cl)=O)=CC=C1C(Cl)=O NTNUPCREDHXJEL-UHFFFAOYSA-N 0.000 description 1
- DEFUMLHLEJNWIO-UHFFFAOYSA-N 2-methylbenzenecarbothioamide Chemical compound CC1=CC=CC=C1C(N)=S DEFUMLHLEJNWIO-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- AAWPBDPLOOSGGF-UHFFFAOYSA-N 2-methylsulfanylbenzoyl chloride Chemical compound CSC1=CC=CC=C1C(Cl)=O AAWPBDPLOOSGGF-UHFFFAOYSA-N 0.000 description 1
- BWWHTIHDQBHTHP-UHFFFAOYSA-N 2-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1C(Cl)=O BWWHTIHDQBHTHP-UHFFFAOYSA-N 0.000 description 1
- UUPZTFTUZUQRQT-UHFFFAOYSA-N 2-thiophen-2-ylacetamide Chemical compound NC(=O)CC1=CC=CS1 UUPZTFTUZUQRQT-UHFFFAOYSA-N 0.000 description 1
- VAYMIYBJLRRIFR-UHFFFAOYSA-N 2-tolyl isocyanate Chemical compound CC1=CC=CC=C1N=C=O VAYMIYBJLRRIFR-UHFFFAOYSA-N 0.000 description 1
- VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical group ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
- JHOHECPIHOWBEL-UHFFFAOYSA-N 3,5-dichloro-n-[2,5-dichloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC(C(=O)NC=2C(=CC(=C(Cl)C=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)Cl)=C1 JHOHECPIHOWBEL-UHFFFAOYSA-N 0.000 description 1
- JZPSFRQQIBRZRW-UHFFFAOYSA-N 3,5-dichloro-n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]benzamide Chemical compound ClC1=CC(Cl)=CC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1 JZPSFRQQIBRZRW-UHFFFAOYSA-N 0.000 description 1
- LOSBMYRZZMSRON-UHFFFAOYSA-N 3,5-dimethyl-4-[(2-methylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=CC=C1C(=O)NC1=C(C)C=C(C(O)=O)C=C1C LOSBMYRZZMSRON-UHFFFAOYSA-N 0.000 description 1
- 125000002981 3-(trifluoromethyl)benzoyl group Chemical group FC(C=1C=C(C(=O)*)C=CC1)(F)F 0.000 description 1
- GWKSSMDJEWPKCM-UHFFFAOYSA-N 3-chloro-1-benzothiophene-2-carbonyl chloride Chemical compound C1=CC=C2C(Cl)=C(C(=O)Cl)SC2=C1 GWKSSMDJEWPKCM-UHFFFAOYSA-N 0.000 description 1
- AZTDCOANQIJCPH-UHFFFAOYSA-N 3-chloro-4-[(2,3-dichlorobenzoyl)amino]benzoic acid Chemical compound ClC1=CC(C(=O)O)=CC=C1NC(=O)C1=CC=CC(Cl)=C1Cl AZTDCOANQIJCPH-UHFFFAOYSA-N 0.000 description 1
- OMWXQFBNAKWUPM-UHFFFAOYSA-N 3-chloro-4-[(2,3-dimethylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=CC(C(=O)NC=2C(=CC(=CC=2)C(O)=O)Cl)=C1C OMWXQFBNAKWUPM-UHFFFAOYSA-N 0.000 description 1
- HEVKLTMTWZPJAZ-UHFFFAOYSA-N 3-chloro-4-[(2,5-dimethylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=C(C)C(C(=O)NC=2C(=CC(=CC=2)C(O)=O)Cl)=C1 HEVKLTMTWZPJAZ-UHFFFAOYSA-N 0.000 description 1
- TXQHFMCPWNDEFV-UHFFFAOYSA-N 3-chloro-4-[(2-methylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(O)=O)C=C1Cl TXQHFMCPWNDEFV-UHFFFAOYSA-N 0.000 description 1
- WERRMUDPOVXWTJ-UHFFFAOYSA-N 3-chloro-4-[(2-methylbenzoyl)amino]benzoyl chloride Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(Cl)=O)C=C1Cl WERRMUDPOVXWTJ-UHFFFAOYSA-N 0.000 description 1
- YLEWHONBUQBJKH-UHFFFAOYSA-N 3-chloro-4-[(3-fluoro-2-methylbenzoyl)amino]benzoic acid Chemical compound CC1=C(F)C=CC=C1C(=O)NC1=CC=C(C(O)=O)C=C1Cl YLEWHONBUQBJKH-UHFFFAOYSA-N 0.000 description 1
- LONAZJRNUKTHTI-UHFFFAOYSA-N 3-chloro-4-[(5-fluoro-2-methylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(O)=O)C=C1Cl LONAZJRNUKTHTI-UHFFFAOYSA-N 0.000 description 1
- IUGCCFWFRCDYRR-UHFFFAOYSA-N 3-chloro-4-[[2-(trifluoromethyl)benzoyl]amino]benzoic acid Chemical compound ClC1=CC(C(=O)O)=CC=C1NC(=O)C1=CC=CC=C1C(F)(F)F IUGCCFWFRCDYRR-UHFFFAOYSA-N 0.000 description 1
- GZUYDFUTKOEQHL-UHFFFAOYSA-N 3-chloro-4-[[4-fluoro-2-(trifluoromethyl)benzoyl]amino]benzoic acid Chemical compound ClC1=CC(C(=O)O)=CC=C1NC(=O)C1=CC=C(F)C=C1C(F)(F)F GZUYDFUTKOEQHL-UHFFFAOYSA-N 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-M 3-chlorobenzoate Chemical compound [O-]C(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-M 0.000 description 1
- XMKZAIHFVHJGPV-UHFFFAOYSA-N 3-fluoro-2-methylbenzoic acid Chemical compound CC1=C(F)C=CC=C1C(O)=O XMKZAIHFVHJGPV-UHFFFAOYSA-N 0.000 description 1
- XDTTUTIFWDAMIX-UHFFFAOYSA-N 3-methyl-4-nitrobenzoic acid Chemical compound CC1=CC(C(O)=O)=CC=C1[N+]([O-])=O XDTTUTIFWDAMIX-UHFFFAOYSA-N 0.000 description 1
- KFZFKJZTTNZEAM-UHFFFAOYSA-N 3-methyl-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]thiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)=C1C KFZFKJZTTNZEAM-UHFFFAOYSA-N 0.000 description 1
- DJULNAQGPMKZQZ-UHFFFAOYSA-N 3-methyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]furan-2-carboxamide Chemical compound C1=COC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)=C1C DJULNAQGPMKZQZ-UHFFFAOYSA-N 0.000 description 1
- PCQZNSRBARAQQS-UHFFFAOYSA-N 3-methyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]thiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)=C1C PCQZNSRBARAQQS-UHFFFAOYSA-N 0.000 description 1
- ISULZYQDGYXDFW-UHFFFAOYSA-N 3-methylbutanoyl chloride Chemical compound CC(C)CC(Cl)=O ISULZYQDGYXDFW-UHFFFAOYSA-N 0.000 description 1
- AJSVPEVDFBYRCH-UHFFFAOYSA-N 3-methylthiophene-2-carbonyl chloride Chemical compound CC=1C=CSC=1C(Cl)=O AJSVPEVDFBYRCH-UHFFFAOYSA-N 0.000 description 1
- HGTGZFQXRMBAAS-UHFFFAOYSA-N 4,6-dihydro-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-one Chemical compound N1C(=O)CC2=NN=CN2C2=CC=CC=C21 HGTGZFQXRMBAAS-UHFFFAOYSA-N 0.000 description 1
- SPFVILPHZTXWPK-UHFFFAOYSA-N 4-[(2,3-dimethylbenzoyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=CC(C)=C1C SPFVILPHZTXWPK-UHFFFAOYSA-N 0.000 description 1
- MYSDKIVLOMXCLI-UHFFFAOYSA-N 4-[(2,4-dichlorobenzoyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=C(Cl)C=C1Cl MYSDKIVLOMXCLI-UHFFFAOYSA-N 0.000 description 1
- SYOJCHZCIOZAOF-UHFFFAOYSA-N 4-[(2,4-dichlorobenzoyl)amino]benzoyl chloride Chemical compound C1=CC(C(=O)Cl)=CC=C1NC(=O)C1=CC=C(Cl)C=C1Cl SYOJCHZCIOZAOF-UHFFFAOYSA-N 0.000 description 1
- VHTPCAKTNNLLTM-UHFFFAOYSA-N 4-[(2,4-dimethoxybenzoyl)-methylamino]benzoic acid Chemical compound COC1=CC(OC)=CC=C1C(=O)N(C)C1=CC=C(C(O)=O)C=C1 VHTPCAKTNNLLTM-UHFFFAOYSA-N 0.000 description 1
- CXRHSARCTBTEFO-UHFFFAOYSA-N 4-[(2,4-dimethylbenzoyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=C(C)C=C1C CXRHSARCTBTEFO-UHFFFAOYSA-N 0.000 description 1
- MUTGMDVHCVJSAB-UHFFFAOYSA-N 4-[(2,5-dichlorobenzoyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC(Cl)=CC=C1Cl MUTGMDVHCVJSAB-UHFFFAOYSA-N 0.000 description 1
- BYPPQEMPXLOINC-UHFFFAOYSA-N 4-[(2-chloro-4-methylbenzoyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=C(C)C=C1Cl BYPPQEMPXLOINC-UHFFFAOYSA-N 0.000 description 1
- TZHGTOLFPZVXMZ-UHFFFAOYSA-N 4-[(2-chlorobenzoyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=CC=C1Cl TZHGTOLFPZVXMZ-UHFFFAOYSA-N 0.000 description 1
- XGRRNXGJZPWONY-UHFFFAOYSA-N 4-[(2-cyclohexylacetyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)CC1CCCCC1 XGRRNXGJZPWONY-UHFFFAOYSA-N 0.000 description 1
- YCLQHASFZMMWMV-UHFFFAOYSA-N 4-[(2-methoxybenzoyl)-methylamino]benzoic acid Chemical compound COC1=CC=CC=C1C(=O)N(C)C1=CC=C(C(O)=O)C=C1 YCLQHASFZMMWMV-UHFFFAOYSA-N 0.000 description 1
- BSPKKSHJCXDTIA-UHFFFAOYSA-N 4-[(2-methylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(O)=O)C=C1 BSPKKSHJCXDTIA-UHFFFAOYSA-N 0.000 description 1
- YAIKYPPELUOPJS-UHFFFAOYSA-N 4-[(3-fluoro-2-methylbenzoyl)amino]benzoic acid Chemical compound CC1=C(F)C=CC=C1C(=O)NC1=CC=C(C(O)=O)C=C1 YAIKYPPELUOPJS-UHFFFAOYSA-N 0.000 description 1
- MPXNLGXOYZMBLP-UHFFFAOYSA-N 4-[(4-chloro-2-methoxybenzoyl)-methylamino]benzoic acid Chemical compound COC1=CC(Cl)=CC=C1C(=O)N(C)C1=CC=C(C(O)=O)C=C1 MPXNLGXOYZMBLP-UHFFFAOYSA-N 0.000 description 1
- HCVAJFCKNPWDRH-UHFFFAOYSA-N 4-[(4-chloro-2-methylbenzoyl)-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=C(Cl)C=C1C HCVAJFCKNPWDRH-UHFFFAOYSA-N 0.000 description 1
- HYNMFQZXCFSVDY-UHFFFAOYSA-N 4-[(5-fluoro-2-methylbenzoyl)amino]benzoic acid Chemical compound CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(O)=O)C=C1 HYNMFQZXCFSVDY-UHFFFAOYSA-N 0.000 description 1
- FOJFEXPUIRIXTD-UHFFFAOYSA-N 4-[2-(2-chlorophenyl)-2-oxoethyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CC(=O)C1=CC=CC=C1Cl FOJFEXPUIRIXTD-UHFFFAOYSA-N 0.000 description 1
- LHVNXNKJTDDJGQ-UHFFFAOYSA-N 4-[[2-(2-chlorophenyl)acetyl]-methylamino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)CC1=CC=CC=C1Cl LHVNXNKJTDDJGQ-UHFFFAOYSA-N 0.000 description 1
- DIUZTUWGVFFCTJ-UHFFFAOYSA-N 4-[[2-(2-methoxyphenyl)acetyl]-methylamino]benzoic acid Chemical compound COC1=CC=CC=C1CC(=O)N(C)C1=CC=C(C(O)=O)C=C1 DIUZTUWGVFFCTJ-UHFFFAOYSA-N 0.000 description 1
- MLKNZFSIQWIIKB-UHFFFAOYSA-N 4-[cyclohex-3-ene-1-carbonyl(methyl)amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1CCC=CC1 MLKNZFSIQWIIKB-UHFFFAOYSA-N 0.000 description 1
- PIXCWFVQRQRQLC-UHFFFAOYSA-N 4-[cyclohexanecarbonyl(methyl)amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1CCCCC1 PIXCWFVQRQRQLC-UHFFFAOYSA-N 0.000 description 1
- FWWJLANFPWBREQ-UHFFFAOYSA-N 4-[methyl-(2-methylbenzenecarbothioyl)amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=S)C1=CC=CC=C1C FWWJLANFPWBREQ-UHFFFAOYSA-N 0.000 description 1
- CNKXSEMZZZZFPM-UHFFFAOYSA-N 4-[methyl-(2-methylbenzoyl)amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=CC=C1C CNKXSEMZZZZFPM-UHFFFAOYSA-N 0.000 description 1
- VLPSMEJKAZDPGX-UHFFFAOYSA-N 4-[methyl-(2-methylbenzoyl)amino]benzoyl chloride Chemical compound C=1C=C(C(Cl)=O)C=CC=1N(C)C(=O)C1=CC=CC=C1C VLPSMEJKAZDPGX-UHFFFAOYSA-N 0.000 description 1
- GJUBKCOXTATZHX-UHFFFAOYSA-N 4-[methyl-(2-methylthiophene-3-carbonyl)amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C=1C=CSC=1C GJUBKCOXTATZHX-UHFFFAOYSA-N 0.000 description 1
- PTXRMSUJDXLBQC-UHFFFAOYSA-N 4-[methyl-(2-phenylacetyl)amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)CC1=CC=CC=C1 PTXRMSUJDXLBQC-UHFFFAOYSA-N 0.000 description 1
- GQGPOGPGEGXXCL-UHFFFAOYSA-N 4-[methyl-(3-methylthiophene-2-carbonyl)amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C=1SC=CC=1C GQGPOGPGEGXXCL-UHFFFAOYSA-N 0.000 description 1
- JGBAWDGOIIJTDQ-UHFFFAOYSA-N 4-[methyl-[2-(2-methylphenyl)acetyl]amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)CC1=CC=CC=C1C JGBAWDGOIIJTDQ-UHFFFAOYSA-N 0.000 description 1
- YOEDZRKGICOGHS-UHFFFAOYSA-N 4-[methyl-[2-(trifluoromethoxy)benzoyl]amino]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1N(C)C(=O)C1=CC=CC=C1OC(F)(F)F YOEDZRKGICOGHS-UHFFFAOYSA-N 0.000 description 1
- MBDUKNCPOPMRJQ-UHFFFAOYSA-N 4-amino-2-chlorobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C(Cl)=C1 MBDUKNCPOPMRJQ-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- HIYDJAGTTQMGKU-UHFFFAOYSA-N 4-chloro-2-methoxy-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound COC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 HIYDJAGTTQMGKU-UHFFFAOYSA-N 0.000 description 1
- SINXXARUIMCGKS-UHFFFAOYSA-N 4-chloro-2-methyl-N-[4-(6-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-3(7),4,10,12-tetraene-8-carbonyl)phenyl]benzamide Chemical compound CC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 SINXXARUIMCGKS-UHFFFAOYSA-N 0.000 description 1
- ZCMBORVTHVUTOE-UHFFFAOYSA-N 4-chloro-2-methyl-n-[4-(4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]benzamide Chemical compound CC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3C2)C=C1 ZCMBORVTHVUTOE-UHFFFAOYSA-N 0.000 description 1
- HGAISTLGQAFCTP-UHFFFAOYSA-N 4-chloro-n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methoxybenzamide Chemical compound COC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl HGAISTLGQAFCTP-UHFFFAOYSA-N 0.000 description 1
- HSDBIXNAPKDUAF-UHFFFAOYSA-N 4-chloro-n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl HSDBIXNAPKDUAF-UHFFFAOYSA-N 0.000 description 1
- AVHIZVSIKRKAGB-UHFFFAOYSA-N 4-chloro-n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 AVHIZVSIKRKAGB-UHFFFAOYSA-N 0.000 description 1
- MGSNAVLNJPNVNM-UHFFFAOYSA-N 4-chloro-n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 MGSNAVLNJPNVNM-UHFFFAOYSA-N 0.000 description 1
- WTQWKIKKHHRNDE-UHFFFAOYSA-N 4-chloro-n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methoxy-n-methylbenzamide Chemical compound COC1=CC(Cl)=CC=C1C(=O)N(C)C1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 WTQWKIKKHHRNDE-UHFFFAOYSA-N 0.000 description 1
- BEUYLWFVBGWTRJ-UHFFFAOYSA-N 4-chloro-n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC(Cl)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)C=C1 BEUYLWFVBGWTRJ-UHFFFAOYSA-N 0.000 description 1
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
- BIUDHHGROGJSHN-UHFFFAOYSA-N 4-fluoro-3-(trifluoromethyl)benzaldehyde Chemical group FC1=CC=C(C=O)C=C1C(F)(F)F BIUDHHGROGJSHN-UHFFFAOYSA-N 0.000 description 1
- VILRNBURKZMTMG-UHFFFAOYSA-N 4-thia-1,8-diazatricyclo[8.3.0.03,7]trideca-2,6,8,10,12-pentaene Chemical compound C1=NC2=CCSC2=CN2C=CC=C21 VILRNBURKZMTMG-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- SVFSWVRLUZKAIT-UHFFFAOYSA-N 4h-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine Chemical compound C1C=NC2=CC=CC=C2N2C=NN=C12 SVFSWVRLUZKAIT-UHFFFAOYSA-N 0.000 description 1
- PCBMMYXQKJIYAP-UHFFFAOYSA-N 4h-furo[2,3-e]-pyrrolo[1,2-a][1,4]diazepine Chemical compound N1=CC2=CC=CN2CC2=C1OC=C2 PCBMMYXQKJIYAP-UHFFFAOYSA-N 0.000 description 1
- ZUWRCVKGUGCDFR-UHFFFAOYSA-N 4h-pyrrolo[1,2-a]thieno[2,3-e][1,4]diazepine Chemical compound N1=CC2=CC=CN2CC2=C1SC=C2 ZUWRCVKGUGCDFR-UHFFFAOYSA-N 0.000 description 1
- DWQJGTMSANDTDT-UHFFFAOYSA-N 5,10-dihydro-4h-[1,2,4]triazolo[3,4-c][1,4]benzodiazepine Chemical compound C1NC2=CC=CC=C2CN2C=NN=C12 DWQJGTMSANDTDT-UHFFFAOYSA-N 0.000 description 1
- LEPAVKIGHTXSIB-UHFFFAOYSA-N 5,11-dihydro-6h-1,3-dioxolo(4,5-h)imidazo(2,1-c)(1,4)benzodiazepine Chemical compound C1N2C=CN=C2CNC2=C1C=C1OCOC1=C2 LEPAVKIGHTXSIB-UHFFFAOYSA-N 0.000 description 1
- QDPUOGCYNFMKFS-UHFFFAOYSA-N 5,7-dihydropyrrolo[1,2-a][1,5]benzodiazepin-6-one Chemical compound N1C(=O)CC2=CC=CN2C2=CC=CC=C21 QDPUOGCYNFMKFS-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- NBFABZHUOJWSDM-UHFFFAOYSA-N 5h-pyrrolo[1,2-a][1,4]diazepine Chemical compound C1C=CN=CC2=CC=CN12 NBFABZHUOJWSDM-UHFFFAOYSA-N 0.000 description 1
- OXVHTMYXGXATQP-UHFFFAOYSA-N 6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl-(2-methoxy-4-nitrophenyl)methanone Chemical compound COC1=CC([N+]([O-])=O)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 OXVHTMYXGXATQP-UHFFFAOYSA-N 0.000 description 1
- LQBWXVADSMSBQC-UHFFFAOYSA-N 6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl-[4-(diphenylphosphorylamino)phenyl]methanone Chemical compound C1C2=CC=CN2CC2=CC=CC=C2N1C(=O)C(C=C1)=CC=C1NP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 LQBWXVADSMSBQC-UHFFFAOYSA-N 0.000 description 1
- OUOOECGGLYNIMA-UHFFFAOYSA-N 6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepin-5-yl-(4-nitrophenyl)methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2CC1 OUOOECGGLYNIMA-UHFFFAOYSA-N 0.000 description 1
- UNDJXWSMKIUPJD-UHFFFAOYSA-N 6h-1,2-benzodiazepine-7-carboxylic acid Chemical compound N1=NC=CC=C2CC(C(=O)O)=CC=C21 UNDJXWSMKIUPJD-UHFFFAOYSA-N 0.000 description 1
- BSYXRAUWWZUXBL-UHFFFAOYSA-N 8-chloro-5,10-dihydro-4h-imidazo[2,1-c][1,4]benzodiazepine Chemical compound N1CC2=NC=CN2CC2=CC(Cl)=CC=C21 BSYXRAUWWZUXBL-UHFFFAOYSA-N 0.000 description 1
- DVLGTOLXGTUWFW-UHFFFAOYSA-N 8-methoxy-5,10-dihydro-4h-imidazo[2,1-c][1,4]benzodiazepine Chemical compound N1CC2=NC=CN2CC2=CC(OC)=CC=C21 DVLGTOLXGTUWFW-UHFFFAOYSA-N 0.000 description 1
- GCKYFBFDDABIEV-UHFFFAOYSA-N 9,10-dihydro-10-(4-aminobenzoyl)-4h-pyrrolo-[1,2-a]thieno[2,3-e]-[1,4]diazepine Chemical compound C1=CC(N)=CC=C1C(=O)N1C(SC=C2)=C2CN2C=CC=C2C1 GCKYFBFDDABIEV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007558 Cardiac failure chronic Diseases 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 229920004937 Dexon® Polymers 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000400611 Eucalyptus deanei Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101100087528 Mus musculus Rhoj gene Proteins 0.000 description 1
- SNWBPAGPLORYQG-UHFFFAOYSA-N N-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-5-methoxyphenyl]-2-methylbenzamide Chemical compound C=1C=CN2C=1CN(C1=C(C2)C=CC=C1)C(=O)C1=C(C=C(C(=C1)Cl)NC(C1=C(C=CC=C1)C)=O)OC SNWBPAGPLORYQG-UHFFFAOYSA-N 0.000 description 1
- MXDYRHKCVGEMAF-UHFFFAOYSA-N NC1=CC=C(C(=O)C2=CC=C3N2C2=CC=CC=C2N=C3)C=C1 Chemical compound NC1=CC=C(C(=O)C2=CC=C3N2C2=CC=CC=C2N=C3)C=C1 MXDYRHKCVGEMAF-UHFFFAOYSA-N 0.000 description 1
- VUYCBBHNGBWOJM-UHFFFAOYSA-N NCOCl Chemical compound NCOCl VUYCBBHNGBWOJM-UHFFFAOYSA-N 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- JLNTWVDSQRNWFU-UHFFFAOYSA-N OOOOOOO Chemical compound OOOOOOO JLNTWVDSQRNWFU-UHFFFAOYSA-N 0.000 description 1
- MOMWFXLCFJOAFX-UHFFFAOYSA-N OOOOOOOO Chemical compound OOOOOOOO MOMWFXLCFJOAFX-UHFFFAOYSA-N 0.000 description 1
- YAVWDJDEOLOYQO-UHFFFAOYSA-N OOOOOOOOOO Chemical compound OOOOOOOOOO YAVWDJDEOLOYQO-UHFFFAOYSA-N 0.000 description 1
- JWOLLWQJKQOEOL-UHFFFAOYSA-N OOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOO JWOLLWQJKQOEOL-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- QCLNYFMNZXNRBG-UHFFFAOYSA-N S1CC=C2N(CC=3N(C=C21)C=CC3)C(=O)C3=CC=C(C=C3)NC(C3=C(C=C(C=C3)Cl)Cl)=O Chemical compound S1CC=C2N(CC=3N(C=C21)C=CC3)C(=O)C3=CC=C(C=C3)NC(C3=C(C=C(C=C3)Cl)Cl)=O QCLNYFMNZXNRBG-UHFFFAOYSA-N 0.000 description 1
- XPEOLVCFPVYLBA-UHFFFAOYSA-N S1CC=C2N(CC=3N(C=C21)C=CC3)C(=O)C3=CC=C(C=C3)NC(C3=C(C=CC=C3)Cl)=O Chemical compound S1CC=C2N(CC=3N(C=C21)C=CC3)C(=O)C3=CC=C(C=C3)NC(C3=C(C=CC=C3)Cl)=O XPEOLVCFPVYLBA-UHFFFAOYSA-N 0.000 description 1
- IGXMRXGINGCSJR-UHFFFAOYSA-N S1CC=C2N(CC=3N(C=C21)C=CC3)C(=O)C3=CC=C(C=C3)NC(C3=C(C=CC=C3OC)OC)=O Chemical compound S1CC=C2N(CC=3N(C=C21)C=CC3)C(=O)C3=CC=C(C=C3)NC(C3=C(C=CC=C3OC)OC)=O IGXMRXGINGCSJR-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 101000649167 Xenopus laevis Zinc finger protein Xfin Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- QPQGTZMAQRXCJW-UHFFFAOYSA-N [chloro(phenyl)phosphoryl]benzene Chemical compound C=1C=CC=CC=1P(=O)(Cl)C1=CC=CC=C1 QPQGTZMAQRXCJW-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 108091008698 baroreceptors Proteins 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000003936 benzamides Chemical class 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 125000003310 benzodiazepinyl group Chemical group N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- WEDIIKBPDQQQJU-UHFFFAOYSA-N butane-1-sulfonyl chloride Chemical compound CCCCS(Cl)(=O)=O WEDIIKBPDQQQJU-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical group 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 238000000262 chemical ionisation mass spectrometry Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 201000011634 coronary artery vasospasm Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- CXWMHIRIXVNVQN-UHFFFAOYSA-N cyclohex-3-ene-1-carbonyl chloride Chemical compound ClC(=O)C1CCC=CC1 CXWMHIRIXVNVQN-UHFFFAOYSA-N 0.000 description 1
- RVOJTCZRIKWHDX-UHFFFAOYSA-N cyclohexanecarbonyl chloride Chemical compound ClC(=O)C1CCCCC1 RVOJTCZRIKWHDX-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- ZWWWLCMDTZFSOO-UHFFFAOYSA-N diethoxyphosphorylformonitrile Chemical compound CCOP(=O)(C#N)OCC ZWWWLCMDTZFSOO-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- VLNZUSMTOFYNPS-UHFFFAOYSA-N diethylphosphorylformonitrile Chemical compound CCP(=O)(CC)C#N VLNZUSMTOFYNPS-UHFFFAOYSA-N 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- VVDUZZGYBOWDSQ-UHFFFAOYSA-M eschenmoser's salt Chemical compound [I-].C[N+](C)=C VVDUZZGYBOWDSQ-UHFFFAOYSA-M 0.000 description 1
- VMQCWXLOLRMYRF-UHFFFAOYSA-N ethyl 3-chloro-4-[(2,4-dichlorobenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=C(Cl)C=C1Cl VMQCWXLOLRMYRF-UHFFFAOYSA-N 0.000 description 1
- PSWBYORTOKSBQZ-UHFFFAOYSA-N ethyl 3-chloro-4-[(2,5-dichlorobenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC(Cl)=CC=C1Cl PSWBYORTOKSBQZ-UHFFFAOYSA-N 0.000 description 1
- GIFQCSDIVFUAFL-UHFFFAOYSA-N ethyl 3-chloro-4-[(2-chlorobenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=CC=C1Cl GIFQCSDIVFUAFL-UHFFFAOYSA-N 0.000 description 1
- PYTQUOGJPICSEI-UHFFFAOYSA-N ethyl 3-chloro-4-[(2-methylbenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=CC=C1C PYTQUOGJPICSEI-UHFFFAOYSA-N 0.000 description 1
- PFRZDJOYZVWCEV-UHFFFAOYSA-N ethyl 3-chloro-4-[(2-methylsulfanylbenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=CC=C1SC PFRZDJOYZVWCEV-UHFFFAOYSA-N 0.000 description 1
- PBKNZOACQUEQDD-UHFFFAOYSA-N ethyl 3-chloro-4-[(3,5-dichlorobenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC(Cl)=CC(Cl)=C1 PBKNZOACQUEQDD-UHFFFAOYSA-N 0.000 description 1
- XAISNCQUVNITRQ-UHFFFAOYSA-N ethyl 3-chloro-4-[(3-fluoro-2-methylbenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=CC(F)=C1C XAISNCQUVNITRQ-UHFFFAOYSA-N 0.000 description 1
- KVDNMPGLULMILI-UHFFFAOYSA-N ethyl 3-chloro-4-[(4-chloro-2-methoxybenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=C(Cl)C=C1OC KVDNMPGLULMILI-UHFFFAOYSA-N 0.000 description 1
- XWMXFOOOFLLYCI-UHFFFAOYSA-N ethyl 3-chloro-4-[(4-chloro-2-methylbenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=C(Cl)C=C1C XWMXFOOOFLLYCI-UHFFFAOYSA-N 0.000 description 1
- OLBDKKGMSRMETJ-UHFFFAOYSA-N ethyl 3-chloro-4-[(4-fluoro-2-methylbenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=C(F)C=C1C OLBDKKGMSRMETJ-UHFFFAOYSA-N 0.000 description 1
- OPCWZORNVFQXLZ-UHFFFAOYSA-N ethyl 3-chloro-4-[(5-fluoro-2-methylbenzoyl)amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC(F)=CC=C1C OPCWZORNVFQXLZ-UHFFFAOYSA-N 0.000 description 1
- RLHVCAYQQFBUPX-UHFFFAOYSA-N ethyl 3-chloro-4-[[4-fluoro-2-(trifluoromethyl)benzoyl]amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=C(F)C=C1C(F)(F)F RLHVCAYQQFBUPX-UHFFFAOYSA-N 0.000 description 1
- SAXUYQAEPCXYQP-UHFFFAOYSA-N ethyl 3-chloro-4-[[4-fluoro-3-(trifluoromethyl)benzoyl]amino]benzoate Chemical compound ClC1=CC(C(=O)OCC)=CC=C1NC(=O)C1=CC=C(F)C(C(F)(F)F)=C1 SAXUYQAEPCXYQP-UHFFFAOYSA-N 0.000 description 1
- PIMARRUOUZIQAS-UHFFFAOYSA-N ethyl 4-(bromomethyl)-3-nitrobenzoate Chemical compound CCOC(=O)C1=CC=C(CBr)C([N+]([O-])=O)=C1 PIMARRUOUZIQAS-UHFFFAOYSA-N 0.000 description 1
- IXSZTVLKNMVNIX-UHFFFAOYSA-N ethyl 4-[methyl-(2-methylbenzoyl)amino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N(C)C(=O)C1=CC=CC=C1C IXSZTVLKNMVNIX-UHFFFAOYSA-N 0.000 description 1
- MFDTVONVIRHHBR-UHFFFAOYSA-N ethyl 4-amino-3-chlorobenzoate Chemical compound CCOC(=O)C1=CC=C(N)C(Cl)=C1 MFDTVONVIRHHBR-UHFFFAOYSA-N 0.000 description 1
- AFYOPMXEGARXJP-UHFFFAOYSA-N ethyl 5-(4-aminobenzoyl)-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-9-carboxylate Chemical compound C12=CC=CC=C2CN2C(C(=O)OCC)=CC=C2CN1C(=O)C1=CC=C(N)C=C1 AFYOPMXEGARXJP-UHFFFAOYSA-N 0.000 description 1
- XFNPOPIOLPFJBD-UHFFFAOYSA-N ethyl 5-[4-[(2-methylbenzoyl)amino]benzoyl]-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-2-carboxylate Chemical compound C1C2=CC=CN2CC2=CC(C(=O)OCC)=CC=C2N1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C XFNPOPIOLPFJBD-UHFFFAOYSA-N 0.000 description 1
- XDCATKJAXTXPFG-UHFFFAOYSA-N ethyl 6,11-dihydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine-2-carboxylate Chemical compound N1CC2=CC=CN2CC2=CC(C(=O)OCC)=CC=C21 XDCATKJAXTXPFG-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- GOLHZPOXCLTFRB-UHFFFAOYSA-N furan-3-carboxamide Chemical compound NC(=O)C=1C=COC=1 GOLHZPOXCLTFRB-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- IENZCGNHSIMFJE-UHFFFAOYSA-N indole-5-carboxylic acid Chemical compound OC(=O)C1=CC=C2NC=CC2=C1 IENZCGNHSIMFJE-UHFFFAOYSA-N 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- TWEQNZZOOFKOER-UHFFFAOYSA-N methyl 3-aminothiophene-2-carboxylate Chemical compound COC(=O)C=1SC=CC=1N TWEQNZZOOFKOER-UHFFFAOYSA-N 0.000 description 1
- NLWBJPPMPLPZIE-UHFFFAOYSA-N methyl 4-(bromomethyl)benzoate Chemical compound COC(=O)C1=CC=C(CBr)C=C1 NLWBJPPMPLPZIE-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- IZYQSMYCWRRWCQ-UHFFFAOYSA-N n-[2,3-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C(=C(Cl)C(C(=O)N3C4=CC=CC=C4CN4C=CC=C4C3)=CC=2)Cl)=C1C IZYQSMYCWRRWCQ-UHFFFAOYSA-N 0.000 description 1
- DWRCPUQMZPKRIB-UHFFFAOYSA-N n-[2,3-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC(C(=C1Cl)Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 DWRCPUQMZPKRIB-UHFFFAOYSA-N 0.000 description 1
- CSRMYVRWWOEAPE-UHFFFAOYSA-N n-[2,3-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-fluoro-2-methylbenzamide Chemical compound CC1=C(F)C=CC=C1C(=O)NC(C(=C1Cl)Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 CSRMYVRWWOEAPE-UHFFFAOYSA-N 0.000 description 1
- HPGCXWZFAMCKAU-UHFFFAOYSA-N n-[2,3-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1C(=O)NC(C(=C1Cl)Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 HPGCXWZFAMCKAU-UHFFFAOYSA-N 0.000 description 1
- FBHOSANWYFXVNC-UHFFFAOYSA-N n-[2,5-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C(=CC(=C(Cl)C=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1C FBHOSANWYFXVNC-UHFFFAOYSA-N 0.000 description 1
- KGDZPNMVIZDSCG-UHFFFAOYSA-N n-[2,5-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC(Cl)=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl KGDZPNMVIZDSCG-UHFFFAOYSA-N 0.000 description 1
- BFRKVGGJRRXAHM-UHFFFAOYSA-N n-[2,5-dichloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-fluoro-2-methylbenzamide Chemical compound CC1=C(F)C=CC=C1C(=O)NC1=CC(Cl)=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl BFRKVGGJRRXAHM-UHFFFAOYSA-N 0.000 description 1
- ZOHASOLLIOGHLY-UHFFFAOYSA-N n-[2,5-dichloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C(=CC(=C(Cl)C=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)Cl)=C1C ZOHASOLLIOGHLY-UHFFFAOYSA-N 0.000 description 1
- CHEMMGMOKRKCFR-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,3-difluorobenzamide Chemical compound FC1=CC=CC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1F CHEMMGMOKRKCFR-UHFFFAOYSA-N 0.000 description 1
- UVHRNDHWEJAAFI-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1C UVHRNDHWEJAAFI-UHFFFAOYSA-N 0.000 description 1
- FSZSTBKQGZNUTF-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,5-difluorobenzamide Chemical compound FC1=CC=C(F)C(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1 FSZSTBKQGZNUTF-UHFFFAOYSA-N 0.000 description 1
- SGRDUDPFJVCUDE-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,5-dimethylbenzamide Chemical compound CC1=CC=C(C)C(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)Cl)=C1 SGRDUDPFJVCUDE-UHFFFAOYSA-N 0.000 description 1
- XKJFOVMSJLDKHS-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,6-dimethylbenzamide Chemical compound CC1=CC=CC(C)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl XKJFOVMSJLDKHS-UHFFFAOYSA-N 0.000 description 1
- DIDLJRDZGKTDMG-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-chlorophenyl)acetamide Chemical compound ClC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl DIDLJRDZGKTDMG-UHFFFAOYSA-N 0.000 description 1
- LVDWNTQGIRPQSP-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl LVDWNTQGIRPQSP-UHFFFAOYSA-N 0.000 description 1
- SZUBIBYKPBCKIT-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-4-fluoro-2-methylbenzamide Chemical compound CC1=CC(F)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl SZUBIBYKPBCKIT-UHFFFAOYSA-N 0.000 description 1
- OUVJTARGMQBOKG-UHFFFAOYSA-N n-[2-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1Cl OUVJTARGMQBOKG-UHFFFAOYSA-N 0.000 description 1
- XVMZOPQRTPNDRX-UHFFFAOYSA-N n-[2-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2,3-difluorobenzamide Chemical compound FC1=CC=CC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)Cl)=C1F XVMZOPQRTPNDRX-UHFFFAOYSA-N 0.000 description 1
- JBAVGENZNKIHPP-UHFFFAOYSA-N n-[2-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-(trifluoromethoxy)benzamide Chemical compound FC(F)(F)OC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1Cl JBAVGENZNKIHPP-UHFFFAOYSA-N 0.000 description 1
- GWCGDSKRGKNNBS-UHFFFAOYSA-N n-[2-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1Cl GWCGDSKRGKNNBS-UHFFFAOYSA-N 0.000 description 1
- DRCJSVOKCHFWFD-UHFFFAOYSA-N n-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4CN4C=CC=C4C3)=CC=2)=C1C DRCJSVOKCHFWFD-UHFFFAOYSA-N 0.000 description 1
- CLXPSMULNJMJGV-UHFFFAOYSA-N n-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 CLXPSMULNJMJGV-UHFFFAOYSA-N 0.000 description 1
- FLHRRQQYWXAFFQ-UHFFFAOYSA-N n-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-fluorobenzamide Chemical compound FC1=CC=CC(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4CN4C=CC=C4C3)=CC=2)=C1 FLHRRQQYWXAFFQ-UHFFFAOYSA-N 0.000 description 1
- DDNOVCPUMMEKDU-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2,3-difluorobenzamide Chemical compound FC1=CC=CC(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4N4C=CC=C4CC3)=CC=2)=C1F DDNOVCPUMMEKDU-UHFFFAOYSA-N 0.000 description 1
- FHBHLPRUBFHSOS-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2,5-difluorobenzamide Chemical compound FC1=CC=C(F)C(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4N4C=CC=C4CC3)=CC=2)=C1 FHBHLPRUBFHSOS-UHFFFAOYSA-N 0.000 description 1
- ZCSRWCQWVOAWMI-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2CC1 ZCSRWCQWVOAWMI-UHFFFAOYSA-N 0.000 description 1
- VDJHCVQCYHDZMM-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2CC1 VDJHCVQCYHDZMM-UHFFFAOYSA-N 0.000 description 1
- ZCLFNRBKWUSFRZ-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-methylfuran-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4N4C=CC=C4CC3)=CC=2)=C1C ZCLFNRBKWUSFRZ-UHFFFAOYSA-N 0.000 description 1
- OXOGTXOFERYBGU-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-methylthiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4N4C=CC=C4CC3)=CC=2)=C1C OXOGTXOFERYBGU-UHFFFAOYSA-N 0.000 description 1
- YNCFMEQORUWOSM-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-3-fluoro-2-methylbenzamide Chemical compound CC1=C(F)C=CC=C1C(=O)NC(C=C1Cl)=CC=C1C(=O)N1C2=CC=CC=C2N2C=CC=C2CC1 YNCFMEQORUWOSM-UHFFFAOYSA-N 0.000 description 1
- MKZAHXOMWIQALG-UHFFFAOYSA-N n-[3-chloro-4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=C(Cl)C(C(=O)N3C4=CC=CC=C4N4C=CC=C4CC3)=CC=2)=C1C MKZAHXOMWIQALG-UHFFFAOYSA-N 0.000 description 1
- OSKCMIWNOBKJBD-UHFFFAOYSA-N n-[4-(1-chloro-4h-pyrrolo[1,2-a]quinoxaline-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C(Cl)=CC=C3C2)C=C1 OSKCMIWNOBKJBD-UHFFFAOYSA-N 0.000 description 1
- DRVWCBBPQIXZTG-UHFFFAOYSA-N n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,6-dimethoxybenzamide Chemical compound COC1=CC=CC(OC)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 DRVWCBBPQIXZTG-UHFFFAOYSA-N 0.000 description 1
- DPINRKFAVHZHRD-UHFFFAOYSA-N n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,6-dimethylbenzamide Chemical compound CC1=CC=CC(C)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 DPINRKFAVHZHRD-UHFFFAOYSA-N 0.000 description 1
- HMDKPOJBRQENBL-UHFFFAOYSA-N n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylfuran-3-yl)acetamide Chemical compound O1C=CC(CC(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)=C1C HMDKPOJBRQENBL-UHFFFAOYSA-N 0.000 description 1
- CEBGKFRCTZWBPJ-UHFFFAOYSA-N n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)C=C1 CEBGKFRCTZWBPJ-UHFFFAOYSA-N 0.000 description 1
- MIQYZHHAEIXXDA-UHFFFAOYSA-N n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylthiophen-3-yl)acetamide Chemical compound S1C=CC(CC(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)=C1C MIQYZHHAEIXXDA-UHFFFAOYSA-N 0.000 description 1
- ONBFEYCZXRUGOC-UHFFFAOYSA-N n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylfuran-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)=C1C ONBFEYCZXRUGOC-UHFFFAOYSA-N 0.000 description 1
- PMXIQASCIIBCEU-UHFFFAOYSA-N n-[4-(4,10-dihydroimidazo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylthiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CN=C3C2)=C1C PMXIQASCIIBCEU-UHFFFAOYSA-N 0.000 description 1
- CLLOKDATBQSLII-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)=C1C CLLOKDATBQSLII-UHFFFAOYSA-N 0.000 description 1
- DUOAELOKJQOMFP-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,4-dimethylbenzamide Chemical compound CC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 DUOAELOKJQOMFP-UHFFFAOYSA-N 0.000 description 1
- GCKUZXNEKAXFEU-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 GCKUZXNEKAXFEU-UHFFFAOYSA-N 0.000 description 1
- WPPCBKWGBILRBR-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(trifluoromethoxy)benzamide Chemical compound FC(F)(F)OC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 WPPCBKWGBILRBR-UHFFFAOYSA-N 0.000 description 1
- ZWQQYOGONJVDCV-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 ZWQQYOGONJVDCV-UHFFFAOYSA-N 0.000 description 1
- ROAYTBDBQAJBPL-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzenecarbothioamide Chemical compound CC1=CC=CC=C1C(=S)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)C=C1 ROAYTBDBQAJBPL-UHFFFAOYSA-N 0.000 description 1
- MEMVKARLDVQADB-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylthiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)=C1C MEMVKARLDVQADB-UHFFFAOYSA-N 0.000 description 1
- VRQZAQXTHJDRFG-UHFFFAOYSA-N n-[4-(4,10-dihydropyrazolo[5,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3N=CC=C3C2)=C1C VRQZAQXTHJDRFG-UHFFFAOYSA-N 0.000 description 1
- OKOYUXTUTHJZSS-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)=C1C OKOYUXTUTHJZSS-UHFFFAOYSA-N 0.000 description 1
- GCKUJOUTQHUQPG-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2,4-dimethoxybenzamide Chemical compound COC1=CC(OC)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 GCKUJOUTQHUQPG-UHFFFAOYSA-N 0.000 description 1
- VPVKTVZPWZGBIW-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2,4-dimethylbenzamide Chemical compound CC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 VPVKTVZPWZGBIW-UHFFFAOYSA-N 0.000 description 1
- SNBQRXYVEPRUFG-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2,6-dimethylbenzamide Chemical compound CC1=CC=CC(C)=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 SNBQRXYVEPRUFG-UHFFFAOYSA-N 0.000 description 1
- ZOEMOAQVCWATPH-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2-(2-methylthiophen-3-yl)acetamide Chemical compound S1C=CC(CC(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)=C1C ZOEMOAQVCWATPH-UHFFFAOYSA-N 0.000 description 1
- VDJDEUKGEUVMSR-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2-(trifluoromethoxy)benzamide Chemical compound FC(F)(F)OC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 VDJDEUKGEUVMSR-UHFFFAOYSA-N 0.000 description 1
- MJGIIYHHPGUHKX-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)C=C1 MJGIIYHHPGUHKX-UHFFFAOYSA-N 0.000 description 1
- OSWAYQXROAAUOY-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-2-methylfuran-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)=C1C OSWAYQXROAAUOY-UHFFFAOYSA-N 0.000 description 1
- FBCCDBULMSSSMU-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-3-methylfuran-2-carboxamide Chemical compound C1=COC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)=C1C FBCCDBULMSSSMU-UHFFFAOYSA-N 0.000 description 1
- VLMHSEKTNHXCOP-UHFFFAOYSA-N n-[4-(4,5-dihydro-[1,2,4]triazolo[3,4-d][1,5]benzodiazepine-6-carbonyl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=NN=C3CC2)=C1C VLMHSEKTNHXCOP-UHFFFAOYSA-N 0.000 description 1
- OOPZHQGWZHSXGA-UHFFFAOYSA-N n-[4-(4h-furo[2,3-e]pyrrolo[1,2-a][1,4]-diazepin-10(9h)-ylcarbonyl)phenyl]-2-methyl benzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3OC=CC=3CN3C=CC=C3C2)C=C1 OOPZHQGWZHSXGA-UHFFFAOYSA-N 0.000 description 1
- XFIYSGSRHACCSY-UHFFFAOYSA-N n-[4-(4h-pyrrolo[1,2-a]thieno[2,3-e][1,4]diazepin-10(9h)-ylcarbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3SC=CC=3CN3C=CC=C3C2)C=C1 XFIYSGSRHACCSY-UHFFFAOYSA-N 0.000 description 1
- ZHHPLHJWJNRWTB-UHFFFAOYSA-N n-[4-(5h-pyrrolo[1,2-a]thieno[3,2-e][1,4]diazepin-4(10h)-ylcarbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C=3C=CSC=3CN3C=CC=C3C2)C=C1 ZHHPLHJWJNRWTB-UHFFFAOYSA-N 0.000 description 1
- XXVFTWJFIICPII-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methoxyphenyl]-2,5-dimethylbenzamide Chemical compound COC1=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=CC=C1NC(=O)C1=CC(C)=CC=C1C XXVFTWJFIICPII-UHFFFAOYSA-N 0.000 description 1
- HHBPMNBIOIGXSN-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methoxyphenyl]-3-fluoro-2-methylbenzamide Chemical compound COC1=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=CC=C1NC(=O)C1=CC=CC(F)=C1C HHBPMNBIOIGXSN-UHFFFAOYSA-N 0.000 description 1
- FUBIQAPXOIIFKB-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methoxyphenyl]butane-1-sulfonamide Chemical compound C1=C(OC)C(NS(=O)(=O)CCCC)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 FUBIQAPXOIIFKB-UHFFFAOYSA-N 0.000 description 1
- PLDPWVGDPHFHLO-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]-2,4-dimethoxybenzamide Chemical compound COC1=CC(OC)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1C PLDPWVGDPHFHLO-UHFFFAOYSA-N 0.000 description 1
- CJLNSHZZCLFJPO-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1C CJLNSHZZCLFJPO-UHFFFAOYSA-N 0.000 description 1
- JPODOFOXTJJFQT-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]-2-methylfuran-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C)=C1C JPODOFOXTJJFQT-UHFFFAOYSA-N 0.000 description 1
- IGJDRQRSFNMKII-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]-2-phenylacetamide Chemical compound CC1=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=CC=C1NC(=O)CC1=CC=CC=C1 IGJDRQRSFNMKII-UHFFFAOYSA-N 0.000 description 1
- QNSIVKZVBLDENK-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]-3-methylfuran-2-carboxamide Chemical compound C1=COC(C(=O)NC=2C(=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C)=C1C QNSIVKZVBLDENK-UHFFFAOYSA-N 0.000 description 1
- KSNRXRMCKQMHTH-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-2-methylphenyl]benzamide Chemical compound CC1=CC(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=CC=C1NC(=O)C1=CC=CC=C1 KSNRXRMCKQMHTH-UHFFFAOYSA-N 0.000 description 1
- MICKBPFHYUHRMN-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)-3-methoxyphenyl]-5-fluoro-2-methylbenzamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C(OC)=CC=1NC(=O)C1=CC(F)=CC=C1C MICKBPFHYUHRMN-UHFFFAOYSA-N 0.000 description 1
- QGOKJKVNYIGYAR-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C1C QGOKJKVNYIGYAR-UHFFFAOYSA-N 0.000 description 1
- ZOSNCXGJXYMUEB-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2,5-dimethylbenzamide Chemical compound CC1=CC=C(C)C(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)=C1 ZOSNCXGJXYMUEB-UHFFFAOYSA-N 0.000 description 1
- MIFPHQJIIXSYLJ-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-hydroxybenzamide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 MIFPHQJIIXSYLJ-UHFFFAOYSA-N 0.000 description 1
- XSBASBOWWXNYNW-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=C1 XSBASBOWWXNYNW-UHFFFAOYSA-N 0.000 description 1
- FAIUEFCHXQFIEP-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-methylbutanamide Chemical compound C1=CC(NC(=O)CC(C)C)=CC=C1C(=O)N1C2=CC=CC=C2CN2C=CC=C2C1 FAIUEFCHXQFIEP-UHFFFAOYSA-N 0.000 description 1
- ZSJXZTBHLTVDOS-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-n,2,3-trimethylbenzamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3CN3C=CC=C3C2)C=CC=1N(C)C(=O)C1=CC=CC(C)=C1C ZSJXZTBHLTVDOS-UHFFFAOYSA-N 0.000 description 1
- YCHJQCFGXVWFTB-UHFFFAOYSA-N n-[4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]naphthalene-1-carboxamide Chemical compound C1C2=CC=CN2CC2=CC=CC=C2N1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC2=CC=CC=C12 YCHJQCFGXVWFTB-UHFFFAOYSA-N 0.000 description 1
- MPCQYRWGYRIISF-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)-2-methoxyphenyl]-5-fluoro-2-methylbenzamide Chemical compound COC1=CC(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)=CC=C1NC(=O)C1=CC(F)=CC=C1C MPCQYRWGYRIISF-UHFFFAOYSA-N 0.000 description 1
- FQZPBZFVDXSQQW-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2,3-dimethylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)=C1C FQZPBZFVDXSQQW-UHFFFAOYSA-N 0.000 description 1
- YLOVFGHXOZPCKL-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2,4-dimethylbenzamide Chemical compound CC1=CC(C)=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1 YLOVFGHXOZPCKL-UHFFFAOYSA-N 0.000 description 1
- CMCNLUACHKRBCV-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-(trifluoromethoxy)benzamide Chemical compound FC(F)(F)OC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1 CMCNLUACHKRBCV-UHFFFAOYSA-N 0.000 description 1
- FWTVOVQZEVHCLQ-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1 FWTVOVQZEVHCLQ-UHFFFAOYSA-N 0.000 description 1
- IFGVBYDQWGVPMA-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1 IFGVBYDQWGVPMA-UHFFFAOYSA-N 0.000 description 1
- ODTCUUJUPNHNQW-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-methylbenzenecarbothioamide Chemical compound CC1=CC=CC=C1C(=S)NC1=CC=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=C1 ODTCUUJUPNHNQW-UHFFFAOYSA-N 0.000 description 1
- HNQRNAAJFPAPLT-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-2-phenylacetamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C=CC=1NC(=O)CC1=CC=CC=C1 HNQRNAAJFPAPLT-UHFFFAOYSA-N 0.000 description 1
- JGENGLAJFKHSKO-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-3-methylfuran-2-carboxamide Chemical compound C1=COC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)=C1C JGENGLAJFKHSKO-UHFFFAOYSA-N 0.000 description 1
- SCQHRQINBRAUJE-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[1,2-a][1,5]benzodiazepine-5-carbonyl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)=C1C SCQHRQINBRAUJE-UHFFFAOYSA-N 0.000 description 1
- QTQLEYGSWGHOFD-UHFFFAOYSA-N n-[4-(6,7-dihydropyrrolo[2,1-d][1,5]benzodiazepine-5-carbonyl)-3-methoxyphenyl]-5-fluoro-2-methylbenzamide Chemical compound C=1C=C(C(=O)N2C3=CC=CC=C3N3C=CC=C3CC2)C(OC)=CC=1NC(=O)C1=CC(F)=CC=C1C QTQLEYGSWGHOFD-UHFFFAOYSA-N 0.000 description 1
- DLDINZUJYVNIEQ-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)C=C1 DLDINZUJYVNIEQ-UHFFFAOYSA-N 0.000 description 1
- DVIMDAWHBVZRSF-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-(2-methylthiophen-3-yl)acetamide Chemical compound S1C=CC(CC(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)=C1C DVIMDAWHBVZRSF-UHFFFAOYSA-N 0.000 description 1
- FNYILDVXFBRZRF-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)C=C1 FNYILDVXFBRZRF-UHFFFAOYSA-N 0.000 description 1
- BHXNEUNJMMURAD-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylfuran-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)=C1C BHXNEUNJMMURAD-UHFFFAOYSA-N 0.000 description 1
- BUTNJWZFXDETJO-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-methylthiophene-3-carboxamide Chemical compound S1C=CC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)=C1C BUTNJWZFXDETJO-UHFFFAOYSA-N 0.000 description 1
- ZIYKROOWHDNJKO-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-2-phenylacetamide Chemical compound C12=CC=CC=C2CN2C(Cl)=CC=C2CN1C(=O)C(C=C1)=CC=C1NC(=O)CC1=CC=CC=C1 ZIYKROOWHDNJKO-UHFFFAOYSA-N 0.000 description 1
- UQHZBQFTFBHJLV-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-methylfuran-2-carboxamide Chemical compound C1=COC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)=C1C UQHZBQFTFBHJLV-UHFFFAOYSA-N 0.000 description 1
- KCVQMCWIJDDPPQ-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=CC(=CC=2)C(=O)N2C3=CC=CC=C3CN3C(Cl)=CC=C3C2)=C1C KCVQMCWIJDDPPQ-UHFFFAOYSA-N 0.000 description 1
- HSBOSOHILWVHOP-UHFFFAOYSA-N n-[4-(9-chloro-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]nitramide Chemical compound C1=CC(N[N+](=O)[O-])=CC=C1C(=O)N1C2=CC=CC=C2CN2C(Cl)=CC=C2C1 HSBOSOHILWVHOP-UHFFFAOYSA-N 0.000 description 1
- PXPXEWLMEWHETR-UHFFFAOYSA-N n-[4-[9-(2,2,2-trichloroacetyl)-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl]phenyl]-2-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2C3=CC=CC=C3CN3C(C(=O)C(Cl)(Cl)Cl)=CC=C3C2)C=C1 PXPXEWLMEWHETR-UHFFFAOYSA-N 0.000 description 1
- VFBILHPIHUPBPZ-UHFFFAOYSA-N n-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide Chemical compound CCOC1=CC=CC=C1C(=O)NCC1=COC(C=2C=C(OC(C)C)C(OC(F)F)=CC=2)=N1 VFBILHPIHUPBPZ-UHFFFAOYSA-N 0.000 description 1
- DOWVMJFBDGWVML-UHFFFAOYSA-N n-cyclohexyl-n-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide Chemical compound C1=NC(C=2C=[N+]([O-])C=CC=2)=CN1C(=O)N(C)C1CCCCC1 DOWVMJFBDGWVML-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 108091008707 osmoreceptors Proteins 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- DVCFNCQPOANJGU-UHFFFAOYSA-N oxolane-2-carbonyl chloride Chemical compound ClC(=O)C1CCCO1 DVCFNCQPOANJGU-UHFFFAOYSA-N 0.000 description 1
- GXHAENUAJYZNOA-UHFFFAOYSA-N oxolane-2-carboxamide Chemical compound NC(=O)C1CCCO1 GXHAENUAJYZNOA-UHFFFAOYSA-N 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 239000004031 partial agonist Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- OAHKWDDSKCRNFE-UHFFFAOYSA-N phenylmethanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC=C1 OAHKWDDSKCRNFE-UHFFFAOYSA-N 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 210000001774 pressoreceptor Anatomy 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 description 1
- DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 239000002287 radioligand Substances 0.000 description 1
- 238000003653 radioligand binding assay Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008060 renal absorption Effects 0.000 description 1
- 230000033987 renal water absorption Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000013223 sprague-dawley female rat Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Pregnancy & Childbirth (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10000493A | 1993-07-29 | 1993-07-29 | |
| US10000493 | 1993-07-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI943543A0 FI943543A0 (fi) | 1994-07-28 |
| FI943543L FI943543L (fi) | 1995-01-30 |
| FI110944B true FI110944B (fi) | 2003-04-30 |
Family
ID=22277643
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI943543A FI110944B (fi) | 1993-07-29 | 1994-07-28 | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi |
| FI20011207A FI113868B (fi) | 1993-07-29 | 2001-06-07 | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] [1,5] bentsodiatsepiinien ja [1,2,4] triatsolo [4,3-a] [1,5] bentsodiatsepiinien valmistamiseksi |
| FI20011206A FI113867B (fi) | 1993-07-29 | 2001-06-07 | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] kinoksaliinien valmistamiseksi |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20011207A FI113868B (fi) | 1993-07-29 | 2001-06-07 | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] [1,5] bentsodiatsepiinien ja [1,2,4] triatsolo [4,3-a] [1,5] bentsodiatsepiinien valmistamiseksi |
| FI20011206A FI113867B (fi) | 1993-07-29 | 2001-06-07 | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo [1,2-a] kinoksaliinien valmistamiseksi |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US5516774A (pl) |
| EP (1) | EP0636625B1 (pl) |
| JP (1) | JP3782475B2 (pl) |
| KR (1) | KR100347479B1 (pl) |
| CN (2) | CN1039908C (pl) |
| AT (1) | ATE176234T1 (pl) |
| AU (1) | AU683660B2 (pl) |
| BR (1) | BR1100563A (pl) |
| CA (1) | CA2128956C (pl) |
| CZ (1) | CZ291322B6 (pl) |
| DE (1) | DE69416211T2 (pl) |
| DK (1) | DK0636625T3 (pl) |
| EC (1) | ECSP941137A (pl) |
| ES (1) | ES2129090T3 (pl) |
| FI (3) | FI110944B (pl) |
| GR (1) | GR3030069T3 (pl) |
| HU (1) | HU220707B1 (pl) |
| IL (1) | IL110435A (pl) |
| LV (1) | LV12497B (pl) |
| NO (1) | NO301827B1 (pl) |
| NZ (1) | NZ264115A (pl) |
| PE (1) | PE17895A1 (pl) |
| PH (1) | PH31469A (pl) |
| PL (1) | PL178563B1 (pl) |
| RU (1) | RU2126006C1 (pl) |
| SG (1) | SG47522A1 (pl) |
| SK (1) | SK280836B6 (pl) |
| ZA (1) | ZA945603B (pl) |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5889001A (en) * | 1993-07-29 | 1999-03-30 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| US5733905A (en) * | 1993-07-29 | 1998-03-31 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| US5968930A (en) * | 1993-07-29 | 1999-10-19 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| US5536718A (en) * | 1995-01-17 | 1996-07-16 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| AR002459A1 (es) * | 1995-01-17 | 1998-03-25 | American Cyanamid Co | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion. |
| US5521173A (en) * | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
| US5753648A (en) * | 1995-01-17 | 1998-05-19 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US5756497A (en) * | 1996-03-01 | 1998-05-26 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| NZ335483A (en) * | 1996-11-01 | 2001-09-28 | American Home Prod | 3-carboxamide derivatives of 5H-pyrrolo[2,1-c][1,4]-benzodiazepines as vasopressin antagonists |
| US5880122A (en) * | 1996-11-01 | 1999-03-09 | American Home Products Corporation | 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines |
| AUPO395396A0 (en) * | 1996-12-02 | 1997-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Benzamide derivatives |
| US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
| ATE277050T1 (de) * | 1997-07-30 | 2004-10-15 | Wyeth Corp | Trizyclische vasopressin agoniste |
| US6511974B1 (en) | 1997-07-30 | 2003-01-28 | Wyeth | Tricyclic vasopressin agonists |
| AR018818A1 (es) * | 1998-04-03 | 2001-12-12 | Yamano Masaki | Una composicion farmaceutica para la terapia de un edema. |
| US7138393B2 (en) * | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
| US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
| EP1147115B3 (en) * | 1999-01-19 | 2008-12-24 | Ortho-McNeil Pharmaceutical, Inc. | Tricyclic benzodiazepines as vasopressin receptor antagonists |
| RU2250899C2 (ru) * | 1999-01-19 | 2005-04-27 | Орто-Макнейл Фармасьютикал, Инк. | Трициклические бензодиазепины, фармацевтическая композиция на их основе и способы лечения гипертензии |
| US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
| US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
| US6344451B1 (en) | 1999-02-04 | 2002-02-05 | American Home Products | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| CA2358892A1 (en) * | 1999-02-04 | 2000-08-10 | Robert John Steffan | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| US6620807B1 (en) | 1999-02-04 | 2003-09-16 | Wyeth | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
| FR2791980B1 (fr) * | 1999-04-09 | 2001-07-06 | Sod Conseils Rech Applic | Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant |
| US6420358B1 (en) | 1999-09-27 | 2002-07-16 | American Cyanamid Company | Vasopressin antagonist and diuretic combination |
| HK1045109A1 (zh) * | 1999-09-27 | 2002-11-15 | American Cyanamid Company | 列出後叶加压素拮抗物的公式及步骤 |
| US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
| US6352718B1 (en) | 1999-09-27 | 2002-03-05 | American Cyanamid Company | Vasopressin antagonist formulation and process |
| GB0000079D0 (en) | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| CN1440383A (zh) * | 2000-04-28 | 2003-09-03 | 三共株式会社 | PPARγ调制剂 |
| GB0015601D0 (en) | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
| US7053083B2 (en) * | 2001-04-12 | 2006-05-30 | Wyeth | Cyclohexylphenyl vasopressin agonists |
| BR0208823A (pt) * | 2001-04-12 | 2004-03-09 | Wyeth Corp | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica |
| US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7109193B2 (en) * | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| WO2003035602A1 (en) * | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Lipid modulators |
| RU2338747C2 (ru) * | 2003-03-31 | 2008-11-20 | Каунсил Оф Сайентифик Энд Индастриал Рисерч | ДИМЕРЫ ПИРРОЛО [2, 1-c][1, 4] БЕНЗОДИАЗЕПИНА В КАЧЕСТВЕ ПРОТИВООПУХОЛЕВЫХ СРЕДСТВ И СПОСОБ ИХ ПОЛУЧЕНИЯ |
| RU2314309C2 (ru) * | 2003-03-31 | 2008-01-10 | Каунсил Оф Сайентифик Энд Индастриал Рисерч | Пирроло [2.1-c][1.4] бензодиазепины, способ их получения и фармацевтическая композиция на их основе |
| US7414052B2 (en) * | 2004-03-30 | 2008-08-19 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| GB0412874D0 (en) * | 2004-06-09 | 2004-07-14 | Pfizer Ltd | Novel pharmaceuticals |
| EP1632494A1 (en) * | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
| RU2323939C1 (ru) * | 2006-10-16 | 2008-05-10 | Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУВПО "КубГТУ") | СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ПИРРОЛО[1,2-а][1,4]ДИАЗЕПИНА |
| EP2113178A1 (en) | 2008-04-30 | 2009-11-04 | Philip Morris Products S.A. | An electrically heated smoking system having a liquid storage portion |
| US8420633B2 (en) * | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
| US8461151B2 (en) * | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
| US8492376B2 (en) * | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| US8481528B2 (en) * | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| RU2623209C9 (ru) * | 2010-07-01 | 2018-01-22 | Азеван Фармасьютикалз, Инк. | Способы лечения посттравматического стрессового расстройства |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| US9249161B2 (en) | 2010-12-02 | 2016-02-02 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US8903228B2 (en) | 2011-03-09 | 2014-12-02 | Chong Corporation | Vapor delivery devices and methods |
| WO2012120487A2 (en) | 2011-03-09 | 2012-09-13 | Chong Corporation | Medicant delivery system |
| US9399110B2 (en) | 2011-03-09 | 2016-07-26 | Chong Corporation | Medicant delivery system |
| WO2012151512A2 (en) * | 2011-05-04 | 2012-11-08 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US9328117B2 (en) | 2011-06-17 | 2016-05-03 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| KR102196418B1 (ko) | 2011-09-06 | 2020-12-30 | 니코벤처스 트레이딩 리미티드 | 가열식 끽연 가능 물질 |
| CA2839099C (en) | 2011-09-06 | 2016-06-28 | British American Tobacco (Investments) Limited | Heating smokeable material |
| CN103288829A (zh) * | 2012-02-24 | 2013-09-11 | 中国科学院大连化学物理研究所 | 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓-5-酮的方法 |
| GB201207039D0 (en) | 2012-04-23 | 2012-06-06 | British American Tobacco Co | Heating smokeable material |
| US9624244B2 (en) | 2012-06-06 | 2017-04-18 | Constellation Pharmaceuticals, Inc. | Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| JP6187459B2 (ja) * | 2012-06-22 | 2017-08-30 | 住友化学株式会社 | アミド化合物及びその有害生物防除用途 |
| EP2765128A1 (en) * | 2013-02-07 | 2014-08-13 | Almirall, S.A. | Substituted benzamides with activity towards EP4 receptors |
| CN104059070B (zh) * | 2013-09-17 | 2016-02-10 | 天津药物研究院有限公司 | 利希普坦晶型ⅰ及其制备方法和用途 |
| CN103755707B (zh) * | 2013-09-17 | 2015-11-18 | 天津药物研究院 | 利希普坦晶型ⅱ及其制备方法和用途 |
| CN103694240B (zh) * | 2013-09-18 | 2015-11-18 | 天津药物研究院 | 利希普坦的溶剂合物及其制备方法和用途 |
| CN106687463B (zh) | 2014-06-20 | 2019-04-09 | 星座制药公司 | 一种乙酰胺类化合物的晶型 |
| CN104140429B (zh) * | 2014-07-25 | 2015-11-18 | 天津药物研究院 | 利希普坦晶型ⅴ及其制备方法和用途 |
| CN104710429B (zh) * | 2015-02-04 | 2017-02-22 | 浙江大学 | 手性螺环磷酸催化合成光学活性喹喔啉衍生物的方法 |
| US20170055584A1 (en) | 2015-08-31 | 2017-03-02 | British American Tobacco (Investments) Limited | Article for use with apparatus for heating smokable material |
| US11924930B2 (en) | 2015-08-31 | 2024-03-05 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
| US20170119046A1 (en) | 2015-10-30 | 2017-05-04 | British American Tobacco (Investments) Limited | Apparatus for Heating Smokable Material |
| RU2750151C2 (ru) | 2015-11-20 | 2021-06-22 | Форма Терапьютикс, Инк. | Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1 |
| MX2019014475A (es) * | 2017-06-09 | 2020-08-17 | Palladio Biosciences Inc | Formulaciones de lixivaptan para el tratamiento de enfermedades poliquisticas. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3860600A (en) * | 1972-07-10 | 1975-01-14 | Sterling Drug Inc | Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines |
| EP0382185B1 (en) * | 1989-02-10 | 1994-06-15 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| KR0167349B1 (ko) * | 1989-10-20 | 1999-02-18 | 오스카 아끼히꼬 | 벤조헤테로 고리 화합물 |
| TW199153B (pl) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
| CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
| US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
| EP0533243B1 (en) * | 1991-09-16 | 1997-12-17 | Merck & Co. Inc. | Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives |
| EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
-
1994
- 1994-06-13 US US08/254,822 patent/US5516774A/en not_active Expired - Lifetime
- 1994-07-15 DE DE69416211T patent/DE69416211T2/de not_active Expired - Lifetime
- 1994-07-15 EP EP94111039A patent/EP0636625B1/en not_active Expired - Lifetime
- 1994-07-15 DK DK94111039T patent/DK0636625T3/da active
- 1994-07-15 ES ES94111039T patent/ES2129090T3/es not_active Expired - Lifetime
- 1994-07-15 SG SG1996002643A patent/SG47522A1/en unknown
- 1994-07-15 AT AT94111039T patent/ATE176234T1/de active
- 1994-07-20 SK SK881-94A patent/SK280836B6/sk not_active IP Right Cessation
- 1994-07-25 IL IL11043594A patent/IL110435A/xx not_active IP Right Cessation
- 1994-07-26 CZ CZ19941799A patent/CZ291322B6/cs not_active IP Right Cessation
- 1994-07-26 PE PE1994247526A patent/PE17895A1/es not_active Application Discontinuation
- 1994-07-27 PH PH48700A patent/PH31469A/en unknown
- 1994-07-27 CA CA002128956A patent/CA2128956C/en not_active Expired - Fee Related
- 1994-07-28 EC EC1994001137A patent/ECSP941137A/es unknown
- 1994-07-28 FI FI943543A patent/FI110944B/fi not_active IP Right Cessation
- 1994-07-28 NZ NZ264115A patent/NZ264115A/en not_active IP Right Cessation
- 1994-07-28 AU AU68777/94A patent/AU683660B2/en not_active Ceased
- 1994-07-28 KR KR1019940018496A patent/KR100347479B1/ko not_active Expired - Fee Related
- 1994-07-28 JP JP19585794A patent/JP3782475B2/ja not_active Expired - Lifetime
- 1994-07-28 RU RU94027583A patent/RU2126006C1/ru not_active IP Right Cessation
- 1994-07-28 NO NO942816A patent/NO301827B1/no not_active IP Right Cessation
- 1994-07-28 HU HU9402219A patent/HU220707B1/hu not_active IP Right Cessation
- 1994-07-28 ZA ZA945603A patent/ZA945603B/xx unknown
- 1994-07-29 PL PL94304498A patent/PL178563B1/pl not_active IP Right Cessation
- 1994-07-29 CN CN94108769A patent/CN1039908C/zh not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/468,737 patent/US5624923A/en not_active Expired - Lifetime
-
1997
- 1997-05-13 BR BR1100563-7A patent/BR1100563A/pt active IP Right Grant
-
1998
- 1998-02-10 CN CN98103834A patent/CN1056374C/zh not_active Expired - Fee Related
-
1999
- 1999-04-26 GR GR990401154T patent/GR3030069T3/el unknown
-
2000
- 2000-01-27 LV LVP-00-13A patent/LV12497B/lv unknown
-
2001
- 2001-06-07 FI FI20011207A patent/FI113868B/fi not_active IP Right Cessation
- 2001-06-07 FI FI20011206A patent/FI113867B/fi not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI110944B (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo-, pyratsolo- ja imidatso[2,1-c][1,4]diatsepiinien valmistamiseksi | |
| FI111077B (fi) | Menetelmä terapeuttisesti käyttökelpoisten trisyklisten bentsatsepiinien valmistamiseksi | |
| JP4163252B2 (ja) | 三環式ベンゾアゼピンバソプレッシンアンタゴニスト類 | |
| FI112487B (fi) | Imidatsobentso- ja -tieno[1,4]diatsepiinit | |
| EP0225013B1 (en) | Heterocyclic compounds and their preparation and use | |
| KR20070049635A (ko) | Hcv 복제 저해제 | |
| EA000056B1 (ru) | Трициклические диазепины в качестве антагонистов вазопрессина, способ их получения и способ лечения с использованием трициклических диазепинов | |
| KR20000022297A (ko) | 트리사이클릭 벤즈아제핀 바소프레신 길항제 | |
| JP5526040B2 (ja) | Par1阻害剤としてのトリアゾロピリダジン類、その製造法および薬剤としての使用 | |
| US6900200B2 (en) | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists | |
| WO1997049708A1 (en) | Tricyclic benzazepine vasopressin antagonists | |
| HK1011363B (en) | Tricyclic diazepines vasopressin and oxytocin antagonists | |
| HK1004132B (en) | Tricyclic benzazepine vasopressin antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |